{
  "schema_version": "0.1.0",
  "case_id": "HR-NI031",
  "record_classification": {
    "synthetic": true,
    "banner": "SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD",
    "real_historical_name": true,
    "public_release_status": "draft"
  },
  "identity": {
    "person_id": "NI031",
    "display_name": "Ada Lovelace",
    "aliases": [
      "Augusta Ada King",
      "Augusta Ada Byron"
    ],
    "sex": "female",
    "era": "19th Century",
    "nationality": "English",
    "historical_dates": {
      "birth": {
        "preferred": {
          "iso": "1815-12-10",
          "display": "December 10, 1815",
          "precision": "day",
          "calendar": "gregorian"
        },
        "alternatives": [
          {
            "date": {
              "iso": "1815",
              "display": "1815",
              "precision": "year",
              "calendar": "gregorian"
            },
            "source_ids": [
              "SRC-0008",
              "SRC-0001"
            ],
            "resolution_status": "preferred",
            "note": "Roster year agrees with the cited sources."
          }
        ]
      },
      "death": {
        "preferred": {
          "iso": "1852-11-27",
          "display": "November 27, 1852",
          "precision": "day",
          "calendar": "gregorian"
        },
        "alternatives": [
          {
            "date": {
              "iso": "1852",
              "display": "1852",
              "precision": "year",
              "calendar": "gregorian"
            },
            "source_ids": [
              "SRC-0008",
              "SRC-0001"
            ],
            "resolution_status": "preferred",
            "note": "Roster year agrees with the cited sources."
          }
        ]
      }
    },
    "synthetic_identity": {
      "mrn": "HR-NI031-SYN",
      "ssn": "000-31-6729",
      "date_of_birth": "1990-12-10",
      "name_policy": "real_historical_name",
      "fictional_facility": "St. Posthumous Health Center",
      "fictional_primary_clinician": "Constance Whitley-Adeyemi, MD",
      "fictional_consultant": {
        "name": "Beatrix Lindgren-Osei, MD",
        "specialty": "Gynecologic Oncology"
      }
    }
  },
  "historical_timeline": [
    {
      "event_id": "EVT-0001",
      "date": {
        "iso": "1815-12-10",
        "display": "December 10, 1815",
        "precision": "day",
        "calendar": "gregorian"
      },
      "summary": "Born in Piccadilly, London.",
      "claim_ids": [
        "CLM-0001"
      ]
    },
    {
      "event_id": "EVT-0002",
      "date": {
        "iso": "1829",
        "display": "1829",
        "precision": "year",
        "calendar": "gregorian"
      },
      "summary": "Measles, with a long recovery and a year in bed.",
      "claim_ids": [
        "CLM-0002"
      ]
    },
    {
      "event_id": "EVT-0003",
      "date": {
        "iso": "1835-07-08",
        "display": "July 8, 1835",
        "precision": "day",
        "calendar": "gregorian"
      },
      "summary": "Married; Countess of Lovelace from 1838.",
      "claim_ids": [
        "CLM-0003"
      ]
    },
    {
      "event_id": "EVT-0004",
      "date": {
        "iso": "1837",
        "display": "1837",
        "precision": "year",
        "calendar": "gregorian"
      },
      "summary": "Cholera, with lingering asthma and digestive problems.",
      "claim_ids": [
        "CLM-0004"
      ]
    },
    {
      "event_id": "EVT-0005",
      "date": {
        "iso": "1843",
        "display": "1842 to 1843",
        "precision": "year",
        "calendar": "gregorian"
      },
      "summary": "Translation of Menabrea's article on the Analytical Engine, with her Notes.",
      "claim_ids": [
        "CLM-0006"
      ]
    },
    {
      "event_id": "EVT-0006",
      "date": {
        "iso": "1844",
        "display": "1843 to 1844 and later",
        "precision": "approximate",
        "calendar": "gregorian"
      },
      "summary": "Declining health; several medicines; laudanum and opium.",
      "claim_ids": [
        "CLM-0005",
        "CLM-0007"
      ]
    },
    {
      "event_id": "EVT-0007",
      "date": {
        "iso": "1850",
        "display": "about 1850 to 1852",
        "precision": "approximate",
        "calendar": "gregorian"
      },
      "summary": "Gambling on horses and pawned jewels.",
      "claim_ids": [
        "CLM-0008"
      ]
    },
    {
      "event_id": "EVT-0008",
      "date": {
        "iso": "1851",
        "display": "1851",
        "precision": "year",
        "calendar": "gregorian"
      },
      "summary": "Gravely ill with uterine cancer.",
      "claim_ids": [
        "CLM-0010"
      ]
    },
    {
      "event_id": "EVT-0009",
      "date": {
        "iso": "1852-01",
        "display": "January 1852",
        "precision": "month",
        "calendar": "gregorian"
      },
      "summary": "Wracked with pain as the cancer advanced.",
      "claim_ids": [
        "CLM-0011"
      ]
    },
    {
      "event_id": "EVT-0010",
      "date": {
        "iso": "1852-11-27",
        "display": "November 27, 1852",
        "precision": "day",
        "calendar": "gregorian"
      },
      "summary": "Died in Marylebone, London; owed about 2,000 pounds in gambling debts.",
      "claim_ids": [
        "CLM-0009",
        "CLM-0012"
      ]
    }
  ],
  "claims": [
    {
      "claim_id": "CLM-0001",
      "statement": "Augusta Ada Byron was born on December 10, 1815, in Piccadilly, London, the daughter of the poet Lord Byron and Anne Isabella Byron.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports",
          "locator": "born Augusta Ada Byron on 10 December 1815"
        },
        {
          "source_id": "SRC-0002",
          "relationship": "supports",
          "locator": "born in Piccadilly, Middlesex (now in London)"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0002",
      "statement": "She was often ill as a child. In 1829, at 13, she caught measles, from which she took a long while to recover; she was bedridden for a whole year.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "Documented childhood illness. The brief's 'unable to walk' and later crutches were not found in a fetched source and are not recorded.",
      "source_links": [
        {
          "source_id": "SRC-0002",
          "relationship": "supports",
          "locator": "1829, measles, a long recovery"
        },
        {
          "source_id": "SRC-0003",
          "relationship": "supports",
          "locator": "bedridden for an entire year after a bout with the measles"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0003",
      "statement": "On July 8, 1835, she married William King, who was created an earl in 1838, making her Countess of Lovelace.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports",
          "locator": "married on 8 July 1835"
        },
        {
          "source_id": "SRC-0002",
          "relationship": "supports",
          "locator": "created an Earl in 1838"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0004",
      "statement": "Her health suffered after a bout of cholera in 1837, and she had lingering problems with asthma and her digestive system.",
      "evidence_grade": "D",
      "certainty": "probable",
      "clinical_interpretation": "Documented in a general biography only.",
      "source_links": [
        {
          "source_id": "SRC-0004",
          "relationship": "supports"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0005",
      "statement": "Her doctors gave her painkillers such as laudanum and opium; she reportedly had mood swings and hallucinations.",
      "evidence_grade": "D",
      "certainty": "probable",
      "clinical_interpretation": "Documented in a general biography only; no doses or dates are given. Anchors the modern history of long-term prescribed opium tincture; no substance use disorder is inferred.",
      "source_links": [
        {
          "source_id": "SRC-0004",
          "relationship": "supports"
        }
      ],
      "release_status": "draft",
      "sensitive_content": true
    },
    {
      "claim_id": "CLM-0006",
      "statement": "Between 1842 and 1843 she translated L. F. Menabrea's article on Charles Babbage's Analytical Engine and added her own extensive Notes, published in 1843 under the initials A.A.L. The Notes, which include a method for computing Bernoulli numbers on the engine, are often described as the first published computer program.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "Her mathematical work; anchors the modern goal of clear-headed working hours.",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports",
          "locator": "translated an article and added an elaborate set of Notes"
        },
        {
          "source_id": "SRC-0002",
          "relationship": "supports",
          "locator": "published in 1843 under the initials AAL; Bernoulli numbers"
        },
        {
          "source_id": "SRC-0007",
          "relationship": "supports",
          "locator": "the 1843 paper; her ill-health curtailed her mathematical ambitions"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0007",
      "statement": "Her health, always fragile, declined sharply after 1843. By the end of that year she was taking several medicines for different health problems; in 1844 she wrote that a recent illness had left her 'utterly unable to think even of my studies', and she thought of writing a scientific study of the effects of opium and wine based on her own experience. In the 1840s she had what she called heart or rheumatic attacks.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "Documented chronic ill health and her own use of opium; no diagnosis is inferred.",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports",
          "locator": "declined dramatically after 1843"
        },
        {
          "source_id": "SRC-0002",
          "relationship": "supports",
          "locator": "several medicines; 1844 letter; opium and wine"
        },
        {
          "source_id": "SRC-0003",
          "relationship": "supports",
          "locator": "heart or rheumatic attacks in the 1840s"
        }
      ],
      "release_status": "draft",
      "sensitive_content": true
    },
    {
      "claim_id": "CLM-0008",
      "statement": "Gambling on horses was a passion of her later years, and she pawned some of her jewels to finance it.",
      "evidence_grade": "D",
      "certainty": "probable",
      "clinical_interpretation": "Documented gambling; the years are not given exactly. No gambling disorder is inferred.",
      "source_links": [
        {
          "source_id": "SRC-0002",
          "relationship": "supports",
          "locator": "gambling on horses; pawned some of her jewels"
        }
      ],
      "release_status": "draft",
      "sensitive_content": true
    },
    {
      "claim_id": "CLM-0009",
      "statement": "As she lay dying it came out that she had led a ruinous horse-betting ring, borrowed money from shady people, and pawned her diamonds twice; she owed about 2,000 pounds in gambling debts when she died.",
      "evidence_grade": "D",
      "certainty": "probable",
      "clinical_interpretation": "After the episode.",
      "source_links": [
        {
          "source_id": "SRC-0005",
          "relationship": "supports",
          "locator": "a ruinous horse-betting ring"
        },
        {
          "source_id": "SRC-0002",
          "relationship": "supports",
          "locator": "2000 pounds in gambling debts"
        }
      ],
      "release_status": "draft",
      "sensitive_content": true
    },
    {
      "claim_id": "CLM-0010",
      "statement": "By 1851 she was extremely sick with uterine cancer.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "Documented; the site is given as the uterus, and the modern episode's cervical primary is a synthetic choice.",
      "source_links": [
        {
          "source_id": "SRC-0003",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0005",
          "relationship": "supports",
          "locator": "dying from uterine cancer"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0011",
      "statement": "By January 1852 she was wracked with pain as the cancer became more acute.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "After the episode.",
      "source_links": [
        {
          "source_id": "SRC-0002",
          "relationship": "supports"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0012",
      "statement": "She died on November 27, 1852, in Marylebone, London, at 36, the age at which her father had died, and was buried at her request next to her father at the Church of St. Mary Magdalene in Hucknall, Nottinghamshire.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "After the episode.",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports",
          "locator": "died at 36 on 27 November 1852, from uterine cancer; buried next to her father"
        },
        {
          "source_id": "SRC-0002",
          "relationship": "supports",
          "locator": "died in Marylebone, London"
        },
        {
          "source_id": "SRC-0004",
          "relationship": "supports",
          "locator": "the Church of St. Mary Magdalene in Hucknall"
        },
        {
          "source_id": "SRC-0006",
          "relationship": "supports",
          "locator": "dying of cancer at 36"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    }
  ],
  "sources": [
    {
      "source_id": "SRC-0001",
      "title": "McCarthy L. About Ada Lovelace (Ada Lovelace blog)",
      "publisher": "Bodleian Libraries, University of Oxford",
      "url": "https://blogs.bodleian.ox.ac.uk/adalovelace/about-ada-lovelace/",
      "source_type": "other",
      "published": null,
      "accessed": "2026-11-06",
      "rights_note": "Library blog; facts used with citation; quoted briefly."
    },
    {
      "source_id": "SRC-0002",
      "title": "O'Connor JJ, Robertson EF. Augusta Ada King, Countess of Lovelace (MacTutor History of Mathematics)",
      "publisher": "University of St Andrews",
      "url": "https://mathshistory.st-andrews.ac.uk/Biographies/Lovelace/",
      "source_type": "scholarly",
      "published": null,
      "accessed": "2026-11-06",
      "rights_note": "Biography; facts used with citation; her own words quoted briefly."
    },
    {
      "source_id": "SRC-0003",
      "title": "Zielinski S. Who Was Ada Lovelace? Smithsonian Magazine, March 24, 2010",
      "publisher": "Smithsonian Magazine",
      "url": "https://www.smithsonianmag.com/science-nature/who-was-ada-lovelace-25830687/",
      "source_type": "other",
      "published": "2010-03-24",
      "accessed": "2026-11-06",
      "rights_note": "Magazine article; facts used with citation."
    },
    {
      "source_id": "SRC-0004",
      "title": "Biography.com Editors. Ada Lovelace Biography (last updated May 6, 2021)",
      "publisher": "A&E Television Networks (Biography.com)",
      "url": "https://www.biography.com/scientist/ada-lovelace",
      "source_type": "other",
      "published": "2021-05-06",
      "accessed": "2026-11-06",
      "rights_note": "General biography; used only where noted and graded probable."
    },
    {
      "source_id": "SRC-0005",
      "title": "Warr T. Review of Miranda Seymour, In Byron's Wake. Historical Novels Review 85 (August 2018)",
      "publisher": "Historical Novel Society",
      "url": "https://historicalnovelsociety.org/?p=22040",
      "source_type": "other",
      "published": "2018-08",
      "accessed": "2026-11-06",
      "rights_note": "Book review quoting the biography's findings; facts used with citation."
    },
    {
      "source_id": "SRC-0006",
      "title": "Augusta Ada King (nee Byron), Countess of Lovelace (Revolution exhibit)",
      "publisher": "Computer History Museum",
      "url": "https://www.computerhistory.org/revolution/calculators/1/51/207",
      "source_type": "other",
      "published": null,
      "accessed": "2026-11-06",
      "rights_note": "Museum exhibit caption; facts used with citation."
    },
    {
      "source_id": "SRC-0007",
      "title": "Exploding the myths of Ada Lovelace's mathematics",
      "publisher": "Mathematical Institute, University of Oxford",
      "url": "https://www.maths.ox.ac.uk/node/25695",
      "source_type": "scholarly",
      "published": null,
      "accessed": "2026-11-06",
      "rights_note": "University research summary; facts used with citation."
    },
    {
      "source_id": "SRC-0008",
      "title": "HISTMED Master Roster v3",
      "publisher": "The Human Record project",
      "url": "https://humanrecord.example.org/internal/HISTMED_Master_Roster_v3.xlsx",
      "source_type": "other",
      "published": "2026-11-06",
      "accessed": "2026-11-06",
      "rights_note": "Internal source locator; inherited claims remain provisional until corroborated."
    }
  ],
  "synthetic_episode": {
    "calendar_frame": "modern_shifted",
    "index_date": "2026-06-02",
    "index_age": 35,
    "date_shift_policy": "HR-DATE-SHIFT-1",
    "teaching_objective": "Primary care, gynecologic oncology and early palliative care for a 35-year-old mathematician with five months of abnormal bleeding and pelvic pain who has taken prescribed opium tincture for years: speculum examination and biopsy of a visible cervical tumor at the first visit, with tumor HPV typing; intravenous iron for iron deficiency anemia from blood loss; conversion of an unmeasured opium tincture to measured oral morphine, then long-acting morphine, with naloxone, a bowel regimen, safe storage and a prescription monitoring check, applying the ASCO 2023 guideline on opioids for cancer pain and noting that the CDC 2022 opioid guideline does not cover cancer pain; FIGO 2018 staging with MRI and PET-CT and biopsy of a lung metastasis (stage IVB); tumor biomarkers (PD-L1, mismatch repair, HER2) and why germline testing is not indicated; palliative pelvic radiation for bleeding; first-line carboplatin, paclitaxel and pembrolizumab under the NCCN cervical cancer guideline and KEYNOTE-826, without bevacizumab while she was bleeding after pelvic radiation; specialist palliative care from diagnosis (ASCO 2024); immune-related thyroid monitoring; opioid-induced constipation; goals-of-care conversations and advance care planning; vaccination of an adult on chemotherapy; and protecting clear-headed hours for her mathematical work.",
    "visit_schedule": [
      {
        "encounter_id": "ENC-001",
        "date": "2026-06-02",
        "purpose": "New patient visit for abnormal bleeding and pelvic pain: history, speculum examination and cervical biopsy, blood count and iron studies, conversion of opium tincture to measured oral morphine, an iron infusion, and a gynecologic oncology referral"
      },
      {
        "encounter_id": "ENC-002",
        "date": "2026-06-16",
        "purpose": "Two-week follow-up and gynecologic oncology consultation: pathology, MRI and PET-CT, staging, treatment intent, palliative care, and long-acting morphine"
      },
      {
        "encounter_id": "ENC-007",
        "date": "2026-07-07",
        "purpose": "Same-day sick visit for constipation"
      },
      {
        "encounter_id": "ENC-003",
        "date": "2026-07-14",
        "purpose": "Six-week review: bleeding and pain after palliative pelvic radiation, the first cycle of chemotherapy with pembrolizumab, blood counts, mood and opioid safety"
      },
      {
        "encounter_id": "ENC-006",
        "date": "2026-08-18",
        "purpose": "Periodic adult preventive visit"
      },
      {
        "encounter_id": "ENC-004",
        "date": "2026-09-08",
        "purpose": "Fourteen-week review: restaging CT, blood counts, iron and thyroid, pain, and a goals-of-care conversation"
      },
      {
        "encounter_id": "ENC-005",
        "date": "2026-10-20",
        "purpose": "Twenty-week review after the last chemotherapy cycle: blood counts, thyroid on pembrolizumab, tapering morphine, mood and her work"
      }
    ]
  },
  "clinical": {
    "problems": [
      {
        "id": "PRB-001",
        "display": "Bleeding between periods and after intercourse, with heavier periods, a watery blood-stained discharge and a constant pelvic ache, for about five months; average pain 7 of 10 despite her opium tincture; a friable cervical mass found on examination and biopsied; cause not yet established at intake",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "N93.8",
            "display": "Other specified abnormal uterine and vaginal bleeding",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic presenting problem anchored to her documented final illness; superseded by the diagnosis at the second visit.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        },
        "clinical_status": "resolved",
        "verification_status": "confirmed",
        "problem_placement": "active",
        "abatement_date": "2026-06-16"
      },
      {
        "id": "PRB-002",
        "display": "Iron deficiency anemia from chronic blood loss: hemoglobin 8.4 g/dL, mean cell volume 74 fL, ferritin 5 ng/mL, with tiredness and breathlessness on stairs",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "D50.0",
            "display": "Iron deficiency anemia secondary to blood loss (chronic)",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic modern finding anchored to her documented final illness.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        },
        "clinical_status": "active",
        "verification_status": "confirmed",
        "problem_placement": "active"
      },
      {
        "id": "PRB-003",
        "display": "Adenocarcinoma of the endocervix, usual (HPV-associated) type, HPV 18 positive, FIGO 2018 stage IVB: a 5.2 cm tumor with left parametrial invasion, metastases to left pelvic and para-aortic lymph nodes, and bilateral lung metastases on MRI and PET-CT; PD-L1 combined positive score 5, mismatch repair proficient, HER2 1+; treated with palliative pelvic radiation for bleeding and carboplatin, paclitaxel and pembrolizumab, with specialist palliative care from diagnosis",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "C53.0",
            "display": "Malignant neoplasm of endocervix",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          },
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "C78.01",
            "display": "Secondary malignant neoplasm of right lung",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          },
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "C78.02",
            "display": "Secondary malignant neoplasm of left lung",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          },
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "C77.2",
            "display": "Secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          },
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "C77.5",
            "display": "Secondary and unspecified malignant neoplasm of intrapelvic lymph nodes",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic modern diagnosis made at the second visit, anchored to her documented uterine cancer; the cervical site is a synthetic choice.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        },
        "clinical_status": "active",
        "verification_status": "confirmed",
        "problem_placement": "active",
        "recorded_date": "2026-06-16"
      },
      {
        "id": "PRB-004",
        "display": "Cancer-related pelvic pain, nociceptive and visceral, from the cervical tumor and its left parametrial extension",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "G89.3",
            "display": "Neoplasm related pain (acute) (chronic)",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic modern diagnosis made at the second visit.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        },
        "clinical_status": "active",
        "verification_status": "confirmed",
        "problem_placement": "active",
        "recorded_date": "2026-06-16"
      },
      {
        "id": "PRB-005",
        "display": "Long-term prescribed opioid therapy: opium tincture for recurrent pelvic and abdominal pain for about two years, measured at times with a household spoon, converted at intake to measured oral morphine; no opioid use disorder on a DSM-5 assessment; naloxone supplied",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "Z79.891",
            "display": "Long term (current) use of opiate analgesic",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005",
            "CLM-0007"
          ],
          "synthetic_reason": "Synthetic modern history anchored to her documented laudanum and opium; not a claim about her real dosing.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        },
        "clinical_status": "active",
        "verification_status": "confirmed",
        "problem_placement": "active"
      },
      {
        "id": "PRB-006",
        "display": "Drug-induced constipation from long-acting morphine and ondansetron, a week after the first chemotherapy cycle: no bowel movement for five days, with bloating and cramping but passing wind, without vomiting; no bowel obstruction on examination; potassium and calcium normal; resolved with laxatives",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "K59.03",
            "display": "Drug induced constipation",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          },
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "T40.2X5A",
            "display": "Adverse effect of other opioids, initial encounter",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic adverse drug effect; not a historical claim.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        },
        "clinical_status": "resolved",
        "verification_status": "confirmed",
        "problem_placement": "active",
        "recorded_date": "2026-07-07"
      }
    ],
    "medications": [
      {
        "id": "MED-001",
        "display": "Opium tincture (100 mg/mL opium, equivalent to 10 mg/mL morphine), 0.5 mL by mouth four to six times a day as needed for pain",
        "status": "completed",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "830196",
            "display": "opium tincture 100 MG/ML Oral Solution",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "dose": {
          "value": 0.5,
          "unit": "mL"
        },
        "route": "oral",
        "frequency": {
          "period": 4,
          "period_unit": "h",
          "text": "0.5 mL four to six times a day as needed"
        },
        "start_date": "2024-06-03",
        "end_date": "2026-06-02",
        "indication_problem_ids": [
          "PRB-005"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005",
            "CLM-0007"
          ],
          "synthetic_reason": "Synthetic long-term prescription by an earlier physician, anchored to her documented laudanum and opium; stopped at intake and converted to measured oral morphine.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "MED-002",
        "display": "Morphine sulfate oral solution 2 mg/mL, 5 mg (2.5 mL by oral syringe) every 4 hours as needed for pain",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "892589",
            "display": "morphine sulfate 2 MG/ML Oral Solution",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "dose": {
          "value": 5,
          "unit": "mg"
        },
        "route": "oral",
        "frequency": {
          "period": 4,
          "period_unit": "h",
          "text": "5 mg every 4 hours as needed"
        },
        "start_date": "2026-06-02",
        "indication_problem_ids": [
          "PRB-001",
          "PRB-005"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic conversion from opium tincture to a measured immediate-release opioid; breakthrough dose from the second visit.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "MED-003",
        "display": "Morphine sulfate extended-release 15 mg tablet, one tablet by mouth every 12 hours; swallow whole",
        "status": "completed",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "891881",
            "display": "morphine sulfate 15 MG Extended Release Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "dose": {
          "value": 15,
          "unit": "mg"
        },
        "route": "oral",
        "frequency": {
          "period": 12,
          "period_unit": "h",
          "text": "every 12 hours"
        },
        "start_date": "2026-06-16",
        "end_date": "2026-10-20",
        "indication_problem_ids": [
          "PRB-004"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic long-acting opioid for constant cancer pain, based on her use of about six as-needed doses a day.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "MED-004",
        "display": "Morphine sulfate extended-release 15 mg tablet, one tablet by mouth at night, for two weeks, then stop",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "891881",
            "display": "morphine sulfate 15 MG Extended Release Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "dose": {
          "value": 15,
          "unit": "mg"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "once at night for two weeks, then stop"
        },
        "start_date": "2026-10-20",
        "indication_problem_ids": [
          "PRB-004"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic taper as pain improved after radiation and chemotherapy.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "MED-005",
        "display": "Naloxone 4 mg nasal spray, one spray in a nostril for suspected opioid overdose; call 911",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "1725059",
            "display": "naloxone hydrochloride 40 MG/ML Nasal Spray",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "dose": {
          "value": 4,
          "unit": "mg"
        },
        "route": "nasal",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "one spray as needed for suspected overdose; repeat after 2 to 3 minutes if needed"
        },
        "start_date": "2026-06-02",
        "indication_problem_ids": [
          "PRB-005"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic naloxone co-prescription with opioid therapy.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "MED-006",
        "display": "Senna 8.6 mg tablet, two tablets by mouth at night",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "312935",
            "display": "sennosides, USP 8.6 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "dose": {
          "value": 17.2,
          "unit": "mg"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "two tablets at night"
        },
        "start_date": "2026-06-02",
        "indication_problem_ids": [
          "PRB-005"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic stimulant laxative started with the opioid.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "MED-007",
        "display": "Polyethylene glycol 3350, 17 g in water by mouth once or twice a day",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "876193",
            "display": "polyethylene glycol 3350 17000 MG Powder for Oral Solution",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "dose": {
          "value": 17,
          "unit": "g"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "once daily, up to twice daily"
        },
        "start_date": "2026-06-02",
        "indication_problem_ids": [
          "PRB-005"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic osmotic laxative started with the opioid.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "MED-008",
        "display": "Acetaminophen 500 mg tablet, two tablets by mouth three times a day",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "198440",
            "display": "acetaminophen 500 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "dose": {
          "value": 1000,
          "unit": "mg"
        },
        "route": "oral",
        "frequency": {
          "period": 8,
          "period_unit": "h",
          "text": "1 g three times a day"
        },
        "start_date": "2026-06-02",
        "indication_problem_ids": [
          "PRB-001",
          "PRB-004"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic non-opioid analgesic; an NSAID is avoided because of bleeding.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "MED-009",
        "display": "Ferric carboxymaltose 750 mg intravenous infusion, two doses at the first two visits",
        "status": "completed",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "1435169",
            "display": "15 ML ferric carboxymaltose 50 MG/ML Injection",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "dose": {
          "value": 750,
          "unit": "mg"
        },
        "route": "intravenous",
        "frequency": {
          "period": 14,
          "period_unit": "d",
          "text": "750 mg on two occasions two weeks apart"
        },
        "start_date": "2026-06-02",
        "end_date": "2026-06-17",
        "indication_problem_ids": [
          "PRB-002"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic intravenous iron for iron deficiency anemia with ongoing bleeding; the course ended with the second infusion.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "MED-010",
        "display": "Pembrolizumab 200 mg intravenously every 3 weeks",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "1657750",
            "display": "4 ML pembrolizumab 25 MG/ML Injection",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "dose": {
          "value": 200,
          "unit": "mg"
        },
        "route": "intravenous",
        "frequency": {
          "period": 3,
          "period_unit": "wk",
          "text": "every 3 weeks"
        },
        "start_date": "2026-06-30",
        "indication_problem_ids": [
          "PRB-003"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic first-line immunotherapy for PD-L1 positive metastatic cervical cancer, given by the oncology infusion unit (KEYNOTE-826).",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "MED-011",
        "display": "Carboplatin, dose to an AUC of 5 (650 mg), intravenously every 3 weeks for six cycles",
        "status": "completed",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "597195",
            "display": "carboplatin 10 MG/ML Injectable Solution",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "dose": {
          "value": 650,
          "unit": "mg"
        },
        "route": "intravenous",
        "frequency": {
          "period": 3,
          "period_unit": "wk",
          "text": "every 3 weeks for six cycles"
        },
        "start_date": "2026-06-30",
        "end_date": "2026-10-13",
        "indication_problem_ids": [
          "PRB-003"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic first-line platinum chemotherapy given by the oncology infusion unit.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "MED-012",
        "display": "Paclitaxel 175 mg/m2 (275 mg) intravenously every 3 weeks for six cycles, with premedication",
        "status": "completed",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "312199",
            "display": "paclitaxel 6 MG/ML Injectable Solution",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "dose": {
          "value": 275,
          "unit": "mg"
        },
        "route": "intravenous",
        "frequency": {
          "period": 3,
          "period_unit": "wk",
          "text": "every 3 weeks for six cycles"
        },
        "start_date": "2026-06-30",
        "end_date": "2026-10-13",
        "indication_problem_ids": [
          "PRB-003"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic first-line taxane chemotherapy given by the oncology infusion unit.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "MED-013",
        "display": "Ondansetron 8 mg tablet, one tablet by mouth twice a day for three days after each chemotherapy cycle, then as needed",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "312086",
            "display": "ondansetron 8 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "dose": {
          "value": 8,
          "unit": "mg"
        },
        "route": "oral",
        "frequency": {
          "period": 12,
          "period_unit": "h",
          "text": "twice a day for three days after each cycle, then as needed"
        },
        "start_date": "2026-06-30",
        "indication_problem_ids": [
          "PRB-003"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic antiemetic with chemotherapy.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      }
    ],
    "allergies": [
      {
        "id": "ALG-001",
        "display": "No known allergy",
        "status": "active",
        "assertion": "no_known_allergy",
        "substance": {
          "system": "http://snomed.info/sct",
          "code": "716186003",
          "display": "No known allergy"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic allergy assertion for EHR completeness; not a historical assertion.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      }
    ],
    "observations": [
      {
        "id": "OBS-HGB-V1",
        "display": "Hemoglobin [Mass/volume] in Blood",
        "label": "Hemoglobin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-06-02",
        "value": 8.4,
        "unit": "g/dL",
        "reference_range": {
          "low": 12.0,
          "high": 15.5
        },
        "interpretation": "L",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "718-7",
            "display": "Hemoglobin [Mass/volume] in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic result in the modern episode; no measurement from her lifetime is used.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-MCV-V1",
        "display": "MCV [Entitic mean volume] in Red Blood Cells by Automated count",
        "label": "Mean cell volume",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-06-02",
        "value": 74,
        "unit": "fL",
        "reference_range": {
          "low": 80,
          "high": 100
        },
        "interpretation": "L",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "787-2",
            "display": "MCV [Entitic mean volume] in Red Blood Cells by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic result in the modern episode; no measurement from her lifetime is used.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-WBC-V1",
        "display": "Leukocytes [#/volume] in Blood by Automated count",
        "label": "White cells",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-06-02",
        "value": 7.8,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 4.0,
          "high": 11.0
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "6690-2",
            "display": "Leukocytes [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic result in the modern episode; no measurement from her lifetime is used.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-PLT-V1",
        "display": "Platelets [#/volume] in Blood by Automated count",
        "label": "Platelets",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-06-02",
        "value": 412,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 150,
          "high": 400
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "777-3",
            "display": "Platelets [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic result in the modern episode; no measurement from her lifetime is used.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-FERR-V1",
        "display": "Ferritin [Mass/volume] in Serum or Plasma",
        "label": "Ferritin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-06-02",
        "value": 5,
        "unit": "ng/mL",
        "reference_range": {
          "low": 15,
          "high": 150
        },
        "interpretation": "L",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2276-4",
            "display": "Ferritin [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic result in the modern episode; no measurement from her lifetime is used.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-CREAT-V1",
        "display": "Creatinine [Mass/volume] in Serum or Plasma",
        "label": "Creatinine",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-06-02",
        "value": 0.68,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.57,
          "high": 1.0
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2160-0",
            "display": "Creatinine [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic result in the modern episode; no measurement from her lifetime is used.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-ALT-V1",
        "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "ALT",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-06-02",
        "value": 18,
        "unit": "U/L",
        "reference_range": {
          "low": 7,
          "high": 35
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1742-6",
            "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic result in the modern episode; no measurement from her lifetime is used.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-ALB-V1",
        "display": "Albumin [Mass/volume] in Serum or Plasma",
        "label": "Albumin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-06-02",
        "value": 3.6,
        "unit": "g/dL",
        "reference_range": {
          "low": 3.5,
          "high": 5.0
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1751-7",
            "display": "Albumin [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic result in the modern episode; no measurement from her lifetime is used.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-HCG-V1",
        "display": "Choriogonadotropin.beta subunit [Units/volume] in Serum or Plasma",
        "label": "Serum hCG",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-06-02",
        "value": 1,
        "unit": "m[IU]/mL",
        "reference_range": {
          "high": 5,
          "text": "Below 5 is negative"
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "21198-7",
            "display": "Choriogonadotropin.beta subunit [Units/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic result in the modern episode; no measurement from her lifetime is used.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-EGFR-V1",
        "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
        "label": "eGFR",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-06-02",
        "value": 116,
        "unit": "mL/min/{1.73_m2}",
        "reference_range": {
          "low": 60,
          "text": "60 or more"
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "98979-8",
            "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic result in the modern episode; no measurement from her lifetime is used.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-PAIN-V1",
        "display": "Pain severity - 0-10 verbal numeric rating [Score] - Reported",
        "label": "Pelvic pain, average over the past week (0 to 10)",
        "status": "final",
        "effective_date": "2026-06-02",
        "value": 7,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "72514-3",
            "display": "Pain severity - 0-10 verbal numeric rating [Score] - Reported",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005",
            "CLM-0007"
          ],
          "synthetic_reason": "Synthetic average pelvic pain over the past week on opium tincture.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-PHQ9-V1",
        "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
        "label": "PHQ-9",
        "status": "final",
        "effective_date": "2026-06-02",
        "value": 8,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "44261-6",
            "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic depression screen at the first visit, mild range, item 9 scored 0; not a diagnosis and not a claim about her real mood.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-HGB-V2",
        "display": "Hemoglobin [Mass/volume] in Blood",
        "label": "Hemoglobin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-06-16",
        "value": 9.0,
        "unit": "g/dL",
        "reference_range": {
          "low": 12.0,
          "high": 15.5
        },
        "interpretation": "L",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "718-7",
            "display": "Hemoglobin [Mass/volume] in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic result two weeks after the first iron infusion; thyroid baseline before immunotherapy.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-CREAT-V2",
        "display": "Creatinine [Mass/volume] in Serum or Plasma",
        "label": "Creatinine",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-06-16",
        "value": 0.66,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.57,
          "high": 1.0
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2160-0",
            "display": "Creatinine [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic result two weeks after the first iron infusion; thyroid baseline before immunotherapy.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-ALT-V2",
        "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "ALT",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-06-16",
        "value": 17,
        "unit": "U/L",
        "reference_range": {
          "low": 7,
          "high": 35
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1742-6",
            "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic result two weeks after the first iron infusion; thyroid baseline before immunotherapy.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-TSH-V2",
        "display": "Thyrotropin [Units/volume] in Serum or Plasma",
        "label": "TSH",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-06-16",
        "value": 1.9,
        "unit": "m[IU]/L",
        "reference_range": {
          "low": 0.45,
          "high": 4.5
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "3016-3",
            "display": "Thyrotropin [Units/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic result two weeks after the first iron infusion; thyroid baseline before immunotherapy.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-FT4-V2",
        "display": "Thyroxine (T4) free [Mass/volume] in Serum or Plasma",
        "label": "Free T4",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-06-16",
        "value": 1.2,
        "unit": "ng/dL",
        "reference_range": {
          "low": 0.8,
          "high": 1.8
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "3024-7",
            "display": "Thyroxine (T4) free [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic result two weeks after the first iron infusion; thyroid baseline before immunotherapy.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-EGFR-V2",
        "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
        "label": "eGFR",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-06-16",
        "value": 117,
        "unit": "mL/min/{1.73_m2}",
        "reference_range": {
          "low": 60,
          "text": "60 or more"
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "98979-8",
            "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic eGFR before chemotherapy.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-PAIN-V2",
        "display": "Pain severity - 0-10 verbal numeric rating [Score] - Reported",
        "label": "Pelvic pain, average over the past week (0 to 10)",
        "status": "final",
        "effective_date": "2026-06-16",
        "value": 6,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "72514-3",
            "display": "Pain severity - 0-10 verbal numeric rating [Score] - Reported",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic average pelvic pain over the past week on oral morphine as needed.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-K-V7",
        "display": "Potassium [Moles/volume] in Serum or Plasma",
        "label": "Potassium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-07-07",
        "value": 3.8,
        "unit": "mmol/L",
        "reference_range": {
          "low": 3.5,
          "high": 5.1
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2823-3",
            "display": "Potassium [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic potassium and calcium at the sick visit for constipation, to exclude metabolic causes.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-CA-V7",
        "display": "Calcium [Mass/volume] in Serum or Plasma",
        "label": "Calcium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-07-07",
        "value": 9.3,
        "unit": "mg/dL",
        "reference_range": {
          "low": 8.6,
          "high": 10.3
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "17861-6",
            "display": "Calcium [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic potassium and calcium at the sick visit for constipation, to exclude metabolic causes.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-HGB-V3",
        "display": "Hemoglobin [Mass/volume] in Blood",
        "label": "Hemoglobin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-07-14",
        "value": 9.8,
        "unit": "g/dL",
        "reference_range": {
          "low": 12.0,
          "high": 15.5
        },
        "interpretation": "L",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "718-7",
            "display": "Hemoglobin [Mass/volume] in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic result two weeks after the first cycle of chemotherapy with pembrolizumab.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-WBC-V3",
        "display": "Leukocytes [#/volume] in Blood by Automated count",
        "label": "White cells",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-07-14",
        "value": 4.1,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 4.0,
          "high": 11.0
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "6690-2",
            "display": "Leukocytes [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic result two weeks after the first cycle of chemotherapy with pembrolizumab.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-ANC-V3",
        "display": "Neutrophils [#/volume] in Blood by Automated count",
        "label": "Neutrophils",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-07-14",
        "value": 2.2,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 1.8,
          "high": 7.7
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "751-8",
            "display": "Neutrophils [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic result two weeks after the first cycle of chemotherapy with pembrolizumab.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-PLT-V3",
        "display": "Platelets [#/volume] in Blood by Automated count",
        "label": "Platelets",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-07-14",
        "value": 236,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 150,
          "high": 400
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "777-3",
            "display": "Platelets [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic result two weeks after the first cycle of chemotherapy with pembrolizumab.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-CREAT-V3",
        "display": "Creatinine [Mass/volume] in Serum or Plasma",
        "label": "Creatinine",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-07-14",
        "value": 0.7,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.57,
          "high": 1.0
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2160-0",
            "display": "Creatinine [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic result two weeks after the first cycle of chemotherapy with pembrolizumab.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-ALT-V3",
        "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "ALT",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-07-14",
        "value": 22,
        "unit": "U/L",
        "reference_range": {
          "low": 7,
          "high": 35
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1742-6",
            "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic result two weeks after the first cycle of chemotherapy with pembrolizumab.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-EGFR-V3",
        "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
        "label": "eGFR",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-07-14",
        "value": 116,
        "unit": "mL/min/{1.73_m2}",
        "reference_range": {
          "low": 60,
          "text": "60 or more"
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "98979-8",
            "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic eGFR on chemotherapy.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-PAIN-V3",
        "display": "Pain severity - 0-10 verbal numeric rating [Score] - Reported",
        "label": "Pelvic pain, average over the past week (0 to 10)",
        "status": "final",
        "effective_date": "2026-07-14",
        "value": 3,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "72514-3",
            "display": "Pain severity - 0-10 verbal numeric rating [Score] - Reported",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic average pelvic pain after palliative pelvic radiation, on morphine.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-PHQ9-V3",
        "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
        "label": "PHQ-9",
        "status": "final",
        "effective_date": "2026-07-14",
        "value": 9,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "44261-6",
            "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic repeat depression screen after the diagnosis, mild range, item 9 scored 0.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-HGB-V4",
        "display": "Hemoglobin [Mass/volume] in Blood",
        "label": "Hemoglobin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-09-08",
        "value": 10.6,
        "unit": "g/dL",
        "reference_range": {
          "low": 12.0,
          "high": 15.5
        },
        "interpretation": "L",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "718-7",
            "display": "Hemoglobin [Mass/volume] in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic result after four cycles of chemotherapy with pembrolizumab.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-WBC-V4",
        "display": "Leukocytes [#/volume] in Blood by Automated count",
        "label": "White cells",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-09-08",
        "value": 3.8,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 4.0,
          "high": 11.0
        },
        "interpretation": "L",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "6690-2",
            "display": "Leukocytes [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic result after four cycles of chemotherapy with pembrolizumab.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-ANC-V4",
        "display": "Neutrophils [#/volume] in Blood by Automated count",
        "label": "Neutrophils",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-09-08",
        "value": 1.9,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 1.8,
          "high": 7.7
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "751-8",
            "display": "Neutrophils [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic result after four cycles of chemotherapy with pembrolizumab.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-PLT-V4",
        "display": "Platelets [#/volume] in Blood by Automated count",
        "label": "Platelets",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-09-08",
        "value": 172,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 150,
          "high": 400
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "777-3",
            "display": "Platelets [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic result after four cycles of chemotherapy with pembrolizumab.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-CREAT-V4",
        "display": "Creatinine [Mass/volume] in Serum or Plasma",
        "label": "Creatinine",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-09-08",
        "value": 0.72,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.57,
          "high": 1.0
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2160-0",
            "display": "Creatinine [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic result after four cycles of chemotherapy with pembrolizumab.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-ALT-V4",
        "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "ALT",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-09-08",
        "value": 26,
        "unit": "U/L",
        "reference_range": {
          "low": 7,
          "high": 35
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1742-6",
            "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic result after four cycles of chemotherapy with pembrolizumab.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-TSH-V4",
        "display": "Thyrotropin [Units/volume] in Serum or Plasma",
        "label": "TSH",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-09-08",
        "value": 3.4,
        "unit": "m[IU]/L",
        "reference_range": {
          "low": 0.45,
          "high": 4.5
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "3016-3",
            "display": "Thyrotropin [Units/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic result after four cycles of chemotherapy with pembrolizumab.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-FERR-V4",
        "display": "Ferritin [Mass/volume] in Serum or Plasma",
        "label": "Ferritin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-09-08",
        "value": 210,
        "unit": "ng/mL",
        "reference_range": {
          "low": 15,
          "high": 150
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2276-4",
            "display": "Ferritin [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic result after four cycles of chemotherapy with pembrolizumab.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-EGFR-V4",
        "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
        "label": "eGFR",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-09-08",
        "value": 112,
        "unit": "mL/min/{1.73_m2}",
        "reference_range": {
          "low": 60,
          "text": "60 or more"
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "98979-8",
            "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic eGFR on chemotherapy.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-PAIN-V4",
        "display": "Pain severity - 0-10 verbal numeric rating [Score] - Reported",
        "label": "Pelvic pain, average over the past week (0 to 10)",
        "status": "final",
        "effective_date": "2026-09-08",
        "value": 3,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "72514-3",
            "display": "Pain severity - 0-10 verbal numeric rating [Score] - Reported",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic average pelvic pain on morphine.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-PHQ9-V4",
        "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
        "label": "PHQ-9",
        "status": "final",
        "effective_date": "2026-09-08",
        "value": 7,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "44261-6",
            "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic repeat depression screen, mild range.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-HGB-V5",
        "display": "Hemoglobin [Mass/volume] in Blood",
        "label": "Hemoglobin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-20",
        "value": 10.9,
        "unit": "g/dL",
        "reference_range": {
          "low": 12.0,
          "high": 15.5
        },
        "interpretation": "L",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "718-7",
            "display": "Hemoglobin [Mass/volume] in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic result one week after the sixth and last cycle of chemotherapy, on pembrolizumab.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-WBC-V5",
        "display": "Leukocytes [#/volume] in Blood by Automated count",
        "label": "White cells",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-20",
        "value": 4.2,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 4.0,
          "high": 11.0
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "6690-2",
            "display": "Leukocytes [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic result one week after the sixth and last cycle of chemotherapy, on pembrolizumab.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-ANC-V5",
        "display": "Neutrophils [#/volume] in Blood by Automated count",
        "label": "Neutrophils",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-20",
        "value": 2.4,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 1.8,
          "high": 7.7
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "751-8",
            "display": "Neutrophils [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic result one week after the sixth and last cycle of chemotherapy, on pembrolizumab.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-PLT-V5",
        "display": "Platelets [#/volume] in Blood by Automated count",
        "label": "Platelets",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-20",
        "value": 188,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 150,
          "high": 400
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "777-3",
            "display": "Platelets [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic result one week after the sixth and last cycle of chemotherapy, on pembrolizumab.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-CREAT-V5",
        "display": "Creatinine [Mass/volume] in Serum or Plasma",
        "label": "Creatinine",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-20",
        "value": 0.71,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.57,
          "high": 1.0
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2160-0",
            "display": "Creatinine [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic result one week after the sixth and last cycle of chemotherapy, on pembrolizumab.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-ALT-V5",
        "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "ALT",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-20",
        "value": 24,
        "unit": "U/L",
        "reference_range": {
          "low": 7,
          "high": 35
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1742-6",
            "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic result one week after the sixth and last cycle of chemotherapy, on pembrolizumab.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-TSH-V5",
        "display": "Thyrotropin [Units/volume] in Serum or Plasma",
        "label": "TSH",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-20",
        "value": 7.8,
        "unit": "m[IU]/L",
        "reference_range": {
          "low": 0.45,
          "high": 4.5
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "3016-3",
            "display": "Thyrotropin [Units/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic result one week after the sixth and last cycle of chemotherapy, on pembrolizumab.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-FT4-V5",
        "display": "Thyroxine (T4) free [Mass/volume] in Serum or Plasma",
        "label": "Free T4",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-20",
        "value": 1.0,
        "unit": "ng/dL",
        "reference_range": {
          "low": 0.8,
          "high": 1.8
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "3024-7",
            "display": "Thyroxine (T4) free [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic result one week after the sixth and last cycle of chemotherapy, on pembrolizumab.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-EGFR-V5",
        "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
        "label": "eGFR",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-20",
        "value": 114,
        "unit": "mL/min/{1.73_m2}",
        "reference_range": {
          "low": 60,
          "text": "60 or more"
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "98979-8",
            "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic eGFR.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-PAIN-V5",
        "display": "Pain severity - 0-10 verbal numeric rating [Score] - Reported",
        "label": "Pelvic pain, average over the past week (0 to 10)",
        "status": "final",
        "effective_date": "2026-10-20",
        "value": 2,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "72514-3",
            "display": "Pain severity - 0-10 verbal numeric rating [Score] - Reported",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic average pelvic pain on morphine.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-PHQ9-V5",
        "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
        "label": "PHQ-9",
        "status": "final",
        "effective_date": "2026-10-20",
        "value": 5,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "44261-6",
            "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic repeat depression screen, mild range.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-PHQ2-V6",
        "display": "Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]",
        "label": "PHQ-2",
        "status": "final",
        "effective_date": "2026-08-18",
        "value": 2,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "55758-7",
            "display": "Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic same-day depression screen at the preventive visit, below the threshold of 3.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      }
    ],
    "procedures": [
      {
        "id": "PROC-001",
        "display": "Speculum examination with punch biopsy of an exophytic friable cervical mass, with a specimen for high-risk HPV typing; hemostasis with ferric subsulfate",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "51675008",
            "display": "Punch biopsy of cervix",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "period": {
          "start": "2026-06-02",
          "end": "2026-06-02"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic biopsy at the first visit.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "PROC-002",
        "display": "MRI of the pelvis: 5.2 cm endocervical tumor with left parametrial invasion, not reaching the pelvic sidewall; no hydronephrosis; enlarged left external iliac lymph node",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "2690005",
            "display": "MRI of pelvis",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "period": {
          "start": "2026-06-09",
          "end": "2026-06-09"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic staging MRI.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "PROC-003",
        "display": "FDG PET-CT: avid cervical tumor; avid left pelvic and para-aortic lymph nodes; six avid nodules in both lungs up to 1.4 cm; no bone or liver lesions",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "725928006",
            "display": "PET CT FDG (fluorodeoxyglucose) imaging of base of brain to mid-thigh",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "period": {
          "start": "2026-06-11",
          "end": "2026-06-11"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic staging PET-CT.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "PROC-004",
        "display": "CT-guided core biopsy of a right lower lobe lung nodule: metastatic adenocarcinoma, p16 strongly positive and HPV 18 detected, matching the cervical primary; small apical pneumothorax not needing treatment",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "16549591000119109",
            "display": "CT guided percutaneous biopsy of right lung",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "period": {
          "start": "2026-06-19",
          "end": "2026-06-19"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic biopsy to confirm metastatic disease before systemic therapy, as recommended at the consultation.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "PROC-005",
        "display": "Palliative external beam radiation to the pelvis for bleeding and pain, 20 Gy in 5 fractions over five days",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "33195004",
            "display": "External beam radiation therapy procedure",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "period": {
          "start": "2026-06-22",
          "end": "2026-06-26"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic hemostatic radiation, as recommended at the consultation.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "PROC-006",
        "display": "CT of chest, abdomen and pelvis after four cycles: partial response by RECIST 1.1, with the cervical tumor 3.1 cm, lung nodules smaller (largest 0.6 cm) and two resolved, para-aortic nodes below 1 cm; no new lesions",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "418023006",
            "display": "CT of chest, abdomen and pelvis",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "period": {
          "start": "2026-08-31",
          "end": "2026-08-31"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic restaging CT.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "PROC-007",
        "display": "Advance care planning conversation, about 30 minutes",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "713603004",
            "display": "Advance care planning",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "period": {
          "start": "2026-08-18",
          "end": "2026-08-18"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic voluntary advance care planning; no real person is named as her agent.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      }
    ],
    "immunizations": [
      {
        "id": "IMM-001",
        "display": "Pneumococcal conjugate vaccine (PCV20)",
        "status": "completed",
        "date": "2026-08-18",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "216",
            "display": "Pneumococcal conjugate PCV20, polysaccharide CRM197 conjugate, adjuvant, PF",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic single dose for an adult aged 19 to 49 who is immunocompromised by chemotherapy for cancer.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "IMM-002",
        "display": "Recombinant zoster vaccine, dose 1 of 2",
        "status": "completed",
        "date": "2026-08-18",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "187",
            "display": "zoster recombinant",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic first dose for an adult aged 19 or older who is immunocompromised.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "IMM-003",
        "display": "Tdap vaccine",
        "status": "completed",
        "date": "2026-08-18",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "115",
            "display": "Tdap",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic booster; no dose recorded in the last ten years.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "IMM-004",
        "display": "Hepatitis B vaccine, CpG-adjuvanted (two-dose series), dose 1 of 2",
        "status": "completed",
        "date": "2026-08-18",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "189",
            "display": "HepB-CpG",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic first dose; universal hepatitis B vaccination for adults 19 to 59 with no evidence of immunity.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "IMM-005",
        "display": "Influenza vaccine, inactivated, trivalent",
        "status": "completed",
        "date": "2026-10-20",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "140",
            "display": "Influenza, split virus, trivalent, PF",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seasonal dose between chemotherapy cycles.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "IMM-006",
        "display": "COVID-19 mRNA vaccine, current season",
        "status": "completed",
        "date": "2026-10-20",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "312",
            "display": "COVID-19, mRNA, LNP-S, PF, 50 mcg/0.5 mL",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seasonal dose for an immunocompromised adult.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "IMM-007",
        "display": "Recombinant zoster vaccine, dose 2 of 2",
        "status": "completed",
        "date": "2026-10-20",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "187",
            "display": "zoster recombinant",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic second dose, nine weeks after the first.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "IMM-008",
        "display": "Hepatitis B vaccine, CpG-adjuvanted (two-dose series), dose 2 of 2",
        "status": "completed",
        "date": "2026-10-20",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "189",
            "display": "HepB-CpG",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic second dose, nine weeks after the first.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      }
    ],
    "family_history": [
      {
        "id": "FH-001",
        "relationship": {
          "system": "http://terminology.hl7.org/CodeSystem/v3-RoleCode",
          "code": "FTH",
          "display": "father"
        },
        "condition": "A poet; died at 36; cause not recorded in the cited source",
        "provenance": {
          "evidence_grade": "D",
          "claim_ids": [
            "CLM-0001"
          ],
          "synthetic_reason": null,
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      }
    ],
    "past_medical_history": [
      {
        "id": "PMH-001",
        "display": "Measles at 13, with a long recovery and about a year in bed",
        "historical_date": {
          "iso": "1829",
          "display": "1829",
          "precision": "year",
          "calendar": "gregorian"
        },
        "provenance": {
          "evidence_grade": "D",
          "claim_ids": [
            "CLM-0002"
          ],
          "synthetic_reason": null,
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "PMH-002",
        "display": "Cholera at 21, followed by lingering asthma and digestive problems",
        "historical_date": {
          "iso": "1837",
          "display": "1837",
          "precision": "year",
          "calendar": "gregorian"
        },
        "provenance": {
          "evidence_grade": "D",
          "claim_ids": [
            "CLM-0004"
          ],
          "synthetic_reason": null,
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "PMH-003",
        "display": "Chronic ill health from her late twenties, with episodes she called heart or rheumatic attacks, treated with several medicines including laudanum and opium",
        "historical_date": {
          "iso": "1844",
          "display": "from about 1843",
          "precision": "approximate",
          "calendar": "gregorian"
        },
        "provenance": {
          "evidence_grade": "D",
          "claim_ids": [
            "CLM-0005",
            "CLM-0007"
          ],
          "synthetic_reason": null,
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      }
    ],
    "encounters": [
      {
        "id": "ENC-001",
        "display": "New patient visit for abnormal bleeding and pelvic pain: history, speculum examination and cervical biopsy, blood count and iron studies, conversion of opium tincture to measured oral morphine, an iron infusion, and a gynecologic oncology referral",
        "status": "finished",
        "date": "2026-06-02",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "ENC-002",
        "display": "Two-week follow-up and gynecologic oncology consultation: pathology, MRI and PET-CT, staging, treatment intent, palliative care, and long-acting morphine",
        "status": "finished",
        "date": "2026-06-16",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        },
        "visit_type": "chronic_care",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "390906007",
          "display": "Follow-up encounter",
          "validation_status": "validated",
          "validated_on": "2026-11-06"
        },
        "documentation": {
          "chief_complaint": "Two-week follow-up of abnormal bleeding and pelvic pain, with the biopsy, MRI and PET-CT results and gynecologic oncology consultation today",
          "hpi": {
            "narrative": "Mrs. Lovelace returns two weeks after her first visit, on the day of her consultation with Dr. Lindgren-Osei. She stopped the opium tincture as agreed and takes oral morphine solution 5 mg with the oral syringe, about six doses a day; her average pelvic pain over the past week is 6 of 10, and she is not drowsy. The bleeding continues, lighter than before, with a watery discharge. She is a little less breathless on stairs since the iron infusion. Her bowels open every other day on senna and polyethylene glycol. She had the MRI a week ago and the PET-CT five days ago. She asked to hear all the results herself and plainly.",
            "elements": [
              {
                "label": "Pain",
                "value": "Average 6 of 10; oral morphine 5 mg about six times a day; not drowsy"
              },
              {
                "label": "Bleeding",
                "value": "Continuing, lighter; watery discharge"
              },
              {
                "label": "Anemia",
                "value": "Less breathless since the iron infusion"
              },
              {
                "label": "Bowels",
                "value": "Every other day on laxatives"
              },
              {
                "label": "Preference",
                "value": "Wants the results told to her directly"
              }
            ]
          },
          "ros": [
            {
              "system": "Constitutional",
              "status": "positive",
              "finding": "Tired; no fever; weight steady"
            },
            {
              "system": "Genitourinary",
              "status": "positive",
              "finding": "Lighter bleeding and watery discharge; no urinary symptoms"
            },
            {
              "system": "Respiratory",
              "status": "negative",
              "finding": "No cough or hemoptysis"
            },
            {
              "system": "Gastrointestinal",
              "status": "negative",
              "finding": "Bowels every other day; no nausea"
            },
            {
              "system": "Psychiatric",
              "status": "positive",
              "finding": "Anxious about the results; no thoughts of self-harm"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Pale and alert; blood pressure 106/66, pulse 92, weight 54.2 kg"
            },
            {
              "system": "Lymph nodes",
              "finding": "No supraclavicular or inguinal lymph node enlargement"
            },
            {
              "system": "Respiratory",
              "finding": "Clear to auscultation"
            },
            {
              "system": "Abdomen",
              "finding": "Soft; mild suprapubic tenderness; no masses or liver enlargement"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-003",
              "display": "Adenocarcinoma of the cervix, FIGO 2018 stage IVB",
              "assessment": "The bleeding and pain now have their explanation. The cervical biopsy shows invasive adenocarcinoma of usual (HPV-associated) type, HPV 18 positive, with PD-L1 combined positive score 5, mismatch repair proficient, and HER2 1+. MRI shows a 5.2 cm tumor with left parametrial invasion; PET-CT shows avid left pelvic and para-aortic lymph nodes and six nodules in both lungs. This is stage IVB by imaging. HIV, hepatitis B and hepatitis C tests before treatment are negative. Dr. Lindgren-Osei and I told her the diagnosis together, as she asked: the cancer cannot be cured, and treatment aims to control it, stop the bleeding and relieve pain, and help her live longer and well",
              "plan": [
                "CT-guided biopsy of a lung nodule to confirm metastatic disease",
                "Palliative pelvic radiation, 20 Gy in 5 fractions, next week, for bleeding and pain",
                "Then carboplatin, paclitaxel and pembrolizumab every 3 weeks; bevacizumab not used while she is bleeding and after pelvic radiation",
                "No germline genetic testing",
                "Specialist palliative care starting today"
              ]
            },
            {
              "problem_id": "PRB-004",
              "display": "Cancer-related pelvic pain",
              "assessment": "Average 6 of 10 on about 30 mg of oral morphine a day in divided doses, without sedation. Constant pain needs a long-acting opioid",
              "plan": [
                "Long-acting morphine 15 mg every 12 hours",
                "Oral morphine solution 5 mg every 4 hours as needed for breakthrough pain",
                "Continue acetaminophen 1 g three times a day and the laxatives every day"
              ]
            },
            {
              "problem_id": "PRB-002",
              "display": "Iron deficiency anemia from blood loss",
              "assessment": "Hemoglobin 9.0 g/dL, from 8.4, two weeks after the first iron infusion, with bleeding continuing; no transfusion needed",
              "plan": [
                "Second ferric carboxymaltose 750 mg infusion today",
                "Ferritin 6 to 8 weeks from now"
              ]
            },
            {
              "problem_id": "PRB-005",
              "display": "Long-term opioid therapy",
              "assessment": "Using the measured morphine as directed, from this one prescriber; no signs of opioid use disorder",
              "plan": [
                "Naloxone at home; morphine in a locked box",
                "Prescription monitoring program checked: no other prescribers"
              ]
            }
          ],
          "monitoring": [
            {
              "domain": "laboratory",
              "measure": "Blood count (hemoglobin, white cells, neutrophils, platelets)",
              "cadence": "Before each chemotherapy cycle and at each visit",
              "status": "completed_today",
              "detail": "Hemoglobin 9.0 g/dL; full count before the first cycle",
              "observation_ids": [
                "OBS-HGB-V2"
              ],
              "guideline_ids": [
                "GL-NCCN-CERV-2026",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Creatinine, eGFR and ALT",
              "cadence": "Before each cycle",
              "status": "completed_today",
              "detail": "Creatinine 0.66 mg/dL, eGFR 117, ALT 17 U/L",
              "observation_ids": [
                "OBS-CREAT-V2",
                "OBS-EGFR-V2",
                "OBS-ALT-V2"
              ],
              "guideline_ids": [
                "GL-NCCN-CERV-2026",
                "GL-KN826-2021"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "TSH and free T4 on pembrolizumab",
              "cadence": "Baseline, then every 6 weeks",
              "status": "completed_today",
              "detail": "Baseline TSH 1.9 mIU/L, free T4 1.2 ng/dL before pembrolizumab",
              "observation_ids": [
                "OBS-TSH-V2",
                "OBS-FT4-V2"
              ],
              "guideline_ids": [
                "GL-ASCO-IRAE-2021"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "HIV, hepatitis B and hepatitis C before cancer treatment",
              "cadence": "Once, before treatment",
              "status": "completed_today",
              "detail": "All negative; hepatitis B surface antibody negative, so vaccination is due",
              "guideline_ids": [
                "GL-ASCO-HBV-2020"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Ferritin after intravenous iron",
              "cadence": "6 to 8 weeks after the infusions",
              "status": "due",
              "detail": "Due 6 to 8 weeks after today's second infusion",
              "guideline_ids": [
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "examination",
              "measure": "Vaginal bleeding and transfusion need",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "Continuing, lighter; no transfusion needed",
              "guideline_ids": [
                "GL-NCCN-CERV-2026"
              ]
            },
            {
              "domain": "imaging",
              "measure": "Staging: pelvic MRI and PET-CT",
              "cadence": "At diagnosis",
              "status": "completed_today",
              "detail": "Stage IVB by imaging; lung biopsy to confirm",
              "guideline_ids": [
                "GL-NCCN-CERV-2026",
                "GL-FIGO-2018"
              ]
            },
            {
              "domain": "survey",
              "measure": "Pain intensity (0 to 10) and function",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "Average 6 of 10",
              "observation_ids": [
                "OBS-PAIN-V2"
              ],
              "guideline_ids": [
                "GL-ASCO-OPIOID-2023"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Opioid adverse effects: sedation, confusion, nausea",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "No sedation, confusion or nausea",
              "guideline_ids": [
                "GL-ASCO-OPIOID-2023"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Bowel regimen and constipation",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "Every other day on senna and polyethylene glycol",
              "guideline_ids": [
                "GL-ASCO-OPIOID-2023"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Naloxone, locked storage, one prescriber, prescription monitoring check",
              "cadence": "At each opioid change",
              "status": "completed_today",
              "detail": "Naloxone at home; locked storage; one prescriber; monitoring check clear",
              "guideline_ids": [
                "GL-ASCO-OPIOID-2023",
                "GL-CDC-OPIOID-2022"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Signs of opioid use disorder",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "None",
              "guideline_ids": [
                "GL-ASCO-OPIOID-2023"
              ]
            },
            {
              "domain": "survey",
              "measure": "Depression screen (PHQ-9) and distress",
              "cadence": "At diagnosis and periodically",
              "status": "up_to_date",
              "detail": "PHQ-9 8 at the first visit; anxious today",
              "guideline_ids": [
                "GL-ASCO-PALL-2024",
                "GL-USPSTF-DEP-2023"
              ]
            },
            {
              "domain": "referral",
              "measure": "Specialist palliative care",
              "cadence": "From diagnosis of advanced cancer",
              "status": "completed_today",
              "detail": "First palliative care visit today",
              "guideline_ids": [
                "GL-ASCO-PALL-2024"
              ]
            },
            {
              "domain": "referral",
              "measure": "Gynecologic oncology consultation",
              "cadence": "Once, at diagnosis",
              "status": "completed_today",
              "detail": "Seen by Dr. Lindgren-Osei today",
              "guideline_ids": [
                "GL-NCCN-CERV-2026"
              ]
            }
          ],
          "follow_up": "Lung biopsy and pelvic radiation in the next ten days. Six-week review in four weeks",
          "guideline_ids": [
            "GL-NCCN-CERV-2026",
            "GL-FIGO-2018",
            "GL-KN826-2021",
            "GL-ASCO-PALL-2024",
            "GL-ASCO-OPIOID-2023",
            "GL-CMID-2026",
            "GL-ASCO-COMM-2026"
          ]
        }
      },
      {
        "id": "ENC-003",
        "display": "Six-week review: bleeding and pain after palliative pelvic radiation, the first cycle of chemotherapy with pembrolizumab, blood counts, mood and opioid safety",
        "status": "finished",
        "date": "2026-07-14",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        },
        "visit_type": "chronic_care",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "390906007",
          "display": "Follow-up encounter",
          "validation_status": "validated",
          "validated_on": "2026-11-06"
        },
        "documentation": {
          "chief_complaint": "Six-week review: bleeding and pain after palliative pelvic radiation, two weeks after the first cycle of chemotherapy with pembrolizumab",
          "hpi": {
            "narrative": "Mrs. Lovelace returns four weeks after the consultation. The lung biopsy three weeks ago confirmed metastatic adenocarcinoma matching the cervical tumor. She completed five days of pelvic radiation, and the bleeding stopped within a week. She had the first cycle of carboplatin, paclitaxel and pembrolizumab two weeks ago, with nausea for two days. The constipation that brought her in a week ago settled within two days of the extra laxatives. Her average pelvic pain is 3 of 10 on long-acting morphine 15 mg twice a day, with a breakthrough dose on some days, and she is clear-headed in the mornings and working again. She feels low at times and finds it hard to sleep the night before treatment. She has no rash, diarrhea, or cough.",
            "elements": [
              {
                "label": "Bleeding",
                "value": "Stopped a week after radiation"
              },
              {
                "label": "Pain",
                "value": "Average 3 of 10; breakthrough dose on some days; clear-headed"
              },
              {
                "label": "Chemotherapy",
                "value": "First cycle two weeks ago; nausea for two days"
              },
              {
                "label": "Bowels",
                "value": "Regular again since the sick visit"
              },
              {
                "label": "Mood",
                "value": "Low at times; PHQ-9 9"
              }
            ]
          },
          "ros": [
            {
              "system": "Genitourinary",
              "status": "negative",
              "finding": "No bleeding; light discharge; no urinary burning"
            },
            {
              "system": "Gastrointestinal",
              "status": "negative",
              "finding": "Bowels regular; no diarrhea"
            },
            {
              "system": "Integumentary",
              "status": "negative",
              "finding": "No rash"
            },
            {
              "system": "Respiratory",
              "status": "negative",
              "finding": "No cough or breathlessness"
            },
            {
              "system": "Psychiatric",
              "status": "positive",
              "finding": "Low at times; poor sleep before treatment; no thoughts of self-harm"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Alert, not sedated; blood pressure 110/70, pulse 84, weight 53.4 kg"
            },
            {
              "system": "Mouth",
              "finding": "No mucositis"
            },
            {
              "system": "Abdomen",
              "finding": "Soft; mild suprapubic tenderness"
            },
            {
              "system": "Neurological",
              "finding": "Sensation normal in the feet"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-003",
              "display": "Metastatic cervical adenocarcinoma, on first-line chemotherapy with pembrolizumab",
              "assessment": "Stage IVB confirmed by the lung biopsy. Radiation has stopped the bleeding. Tolerating the first cycle: white cells 4.1, neutrophils 2.2, platelets 236, creatinine 0.70 mg/dL, ALT 22 U/L, so the second cycle can go ahead next week. No immune-related symptoms",
              "plan": [
                "Second cycle next week as planned",
                "Thyroid tests at six weeks, with the cycle 3 blood tests",
                "Restaging CT after four cycles"
              ]
            },
            {
              "problem_id": "PRB-004",
              "display": "Cancer-related pelvic pain, controlled",
              "assessment": "Average 3 of 10 on long-acting morphine without sedation; she is working in the mornings",
              "plan": [
                "Continue long-acting morphine 15 mg twice a day and 5 mg as needed"
              ]
            },
            {
              "problem_id": "PRB-002",
              "display": "Iron deficiency anemia",
              "assessment": "Hemoglobin 9.8 g/dL and rising, with the bleeding stopped",
              "plan": [
                "Ferritin 6 to 8 weeks after the second infusion"
              ]
            },
            {
              "problem_id": "PRB-005",
              "display": "Long-term opioid therapy",
              "assessment": "Safe use; no sedation; the bowel regimen restored after the sick visit",
              "plan": [
                "Laxatives every day while she takes morphine"
              ]
            }
          ],
          "monitoring": [
            {
              "domain": "laboratory",
              "measure": "Blood count (hemoglobin, white cells, neutrophils, platelets)",
              "cadence": "Before each chemotherapy cycle and at each visit",
              "status": "completed_today",
              "detail": "Hemoglobin 9.8 g/dL, white cells 4.1, neutrophils 2.2, platelets 236",
              "observation_ids": [
                "OBS-HGB-V3",
                "OBS-WBC-V3",
                "OBS-ANC-V3",
                "OBS-PLT-V3"
              ],
              "guideline_ids": [
                "GL-NCCN-CERV-2026",
                "GL-KN826-2021",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Creatinine, eGFR and ALT",
              "cadence": "Before each cycle",
              "status": "completed_today",
              "detail": "Creatinine 0.70 mg/dL, eGFR 116, ALT 22 U/L",
              "observation_ids": [
                "OBS-CREAT-V3",
                "OBS-EGFR-V3",
                "OBS-ALT-V3"
              ],
              "guideline_ids": [
                "GL-NCCN-CERV-2026",
                "GL-KN826-2021"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "TSH and free T4 on pembrolizumab",
              "cadence": "Baseline, then every 6 weeks",
              "status": "due",
              "detail": "Baseline four weeks ago; next due in two weeks, six weeks from baseline",
              "guideline_ids": [
                "GL-ASCO-IRAE-2021"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Ferritin after intravenous iron",
              "cadence": "6 to 8 weeks after the infusions",
              "status": "due",
              "detail": "Due in two to four weeks",
              "guideline_ids": [
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "examination",
              "measure": "Vaginal bleeding and transfusion need",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "No bleeding since radiation",
              "guideline_ids": [
                "GL-NCCN-CERV-2026"
              ]
            },
            {
              "domain": "examination",
              "measure": "Immune-related adverse effects: rash, diarrhea, cough, fatigue",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "None",
              "guideline_ids": [
                "GL-ASCO-IRAE-2021"
              ]
            },
            {
              "domain": "examination",
              "measure": "Peripheral neuropathy on paclitaxel",
              "cadence": "Before each paclitaxel cycle",
              "status": "completed_today",
              "detail": "None",
              "guideline_ids": [
                "GL-NCCN-CERV-2026"
              ]
            },
            {
              "domain": "imaging",
              "measure": "Restaging CT of chest, abdomen and pelvis",
              "cadence": "Every 2 to 3 cycles during first-line therapy, then every 3 months",
              "status": "due",
              "detail": "After four cycles",
              "guideline_ids": [
                "GL-NCCN-CERV-2026"
              ]
            },
            {
              "domain": "survey",
              "measure": "Pain intensity (0 to 10) and function",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "Average 3 of 10",
              "observation_ids": [
                "OBS-PAIN-V3"
              ],
              "guideline_ids": [
                "GL-ASCO-OPIOID-2023"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Opioid adverse effects: sedation, confusion, nausea",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "No sedation; nausea for two days after the cycle",
              "guideline_ids": [
                "GL-ASCO-OPIOID-2023"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Bowel regimen and constipation",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "Constipation a week ago, resolved; daily laxatives",
              "guideline_ids": [
                "GL-ASCO-OPIOID-2023"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Naloxone, locked storage, one prescriber, prescription monitoring check",
              "cadence": "At each opioid change, and every 3 months",
              "status": "up_to_date",
              "detail": "Naloxone at home; locked storage",
              "guideline_ids": [
                "GL-ASCO-OPIOID-2023",
                "GL-CDC-OPIOID-2022"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Signs of opioid use disorder",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "None",
              "guideline_ids": [
                "GL-ASCO-OPIOID-2023"
              ]
            },
            {
              "domain": "survey",
              "measure": "Depression screen (PHQ-9) and distress",
              "cadence": "At diagnosis and periodically",
              "status": "completed_today",
              "detail": "PHQ-9 9, mild; offered and accepted psycho-oncology counseling",
              "observation_ids": [
                "OBS-PHQ9-V3"
              ],
              "guideline_ids": [
                "GL-ASCO-PALL-2024",
                "GL-USPSTF-DEP-2023"
              ]
            },
            {
              "domain": "referral",
              "measure": "Specialist palliative care",
              "cadence": "Ongoing alongside cancer treatment",
              "status": "completed_today",
              "detail": "Seen twice by the palliative care team",
              "guideline_ids": [
                "GL-ASCO-PALL-2024"
              ]
            }
          ],
          "follow_up": "Second cycle next week. Preventive visit in five weeks. Fourteen-week review after the restaging CT",
          "guideline_ids": [
            "GL-NCCN-CERV-2026",
            "GL-KN826-2021",
            "GL-ASCO-IRAE-2021",
            "GL-ASCO-OPIOID-2023",
            "GL-ASCO-PALL-2024",
            "GL-CMID-2026"
          ]
        }
      },
      {
        "id": "ENC-004",
        "display": "Fourteen-week review: restaging CT, blood counts, iron and thyroid, pain, and a goals-of-care conversation",
        "status": "finished",
        "date": "2026-09-08",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        },
        "visit_type": "chronic_care",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "390906007",
          "display": "Follow-up encounter",
          "validation_status": "validated",
          "validated_on": "2026-11-06"
        },
        "documentation": {
          "chief_complaint": "Fourteen-week review after four cycles: restaging CT, blood counts, iron and thyroid, pain, and goals of care",
          "hpi": {
            "narrative": "Mrs. Lovelace returns a week after her fourth cycle. The restaging CT a week ago shows a partial response. She has had no bleeding. Her average pain is 3 of 10 on long-acting morphine 15 mg twice a day, now with a breakthrough dose only once or twice a week. She has mild tingling in her toes that does not affect walking or buttons. She tires for three or four days after each cycle. Her bowels are regular on the laxatives. She has no rash, diarrhea, cough, or cold intolerance. She is working most mornings. She has stopped betting and is meeting the social worker about her debts. The thyroid test due six weeks into treatment and the ferritin due after the iron infusions were not drawn; both were drawn today.",
            "elements": [
              {
                "label": "Response",
                "value": "Partial response on CT after four cycles"
              },
              {
                "label": "Pain",
                "value": "Average 3 of 10; breakthrough dose once or twice a week"
              },
              {
                "label": "Neuropathy",
                "value": "Mild tingling in the toes, no loss of function"
              },
              {
                "label": "Work",
                "value": "Mathematics most mornings"
              },
              {
                "label": "Missed tests",
                "value": "Six-week thyroid test and ferritin drawn today instead"
              }
            ]
          },
          "ros": [
            {
              "system": "Constitutional",
              "status": "positive",
              "finding": "Tired for a few days after each cycle"
            },
            {
              "system": "Neurological",
              "status": "positive",
              "finding": "Mild tingling in the toes"
            },
            {
              "system": "Endocrine",
              "status": "negative",
              "finding": "No cold intolerance or weight gain"
            },
            {
              "system": "Integumentary",
              "status": "negative",
              "finding": "No rash"
            },
            {
              "system": "Psychiatric",
              "status": "negative",
              "finding": "Mood better; counseling helps"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Well, not sedated; blood pressure 112/70, pulse 80, weight 54.0 kg"
            },
            {
              "system": "Neck",
              "finding": "No thyroid enlargement"
            },
            {
              "system": "Respiratory",
              "finding": "Clear"
            },
            {
              "system": "Neurological",
              "finding": "Light touch slightly reduced at the toes; vibration and strength normal; grade 1 neuropathy"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-003",
              "display": "Metastatic cervical adenocarcinoma, partial response",
              "assessment": "CT after four cycles shows a partial response: the cervical tumor 3.1 cm, lung nodules smaller and two gone, para-aortic nodes below 1 cm, no new lesions. Counts allow treatment: white cells 3.8, neutrophils 1.9, platelets 172; creatinine 0.72 mg/dL, ALT 26 U/L. TSH 3.4 mIU/L. Grade 1 neuropathy does not need a dose change",
              "plan": [
                "Complete six cycles of carboplatin and paclitaxel, then continue pembrolizumab every 3 weeks",
                "Restaging CT about three months after this one",
                "Report any worsening numbness, which would lead to a paclitaxel dose reduction"
              ]
            },
            {
              "problem_id": "PRB-002",
              "display": "Iron deficiency anemia, iron replete",
              "assessment": "Hemoglobin 10.6 g/dL without bleeding; ferritin 210 ng/mL, so iron stores are replete; the remaining anemia is from chemotherapy",
              "plan": [
                "No further iron; blood count with each cycle"
              ]
            },
            {
              "problem_id": "PRB-004",
              "display": "Cancer-related pelvic pain, controlled",
              "assessment": "Average 3 of 10 with few breakthrough doses",
              "plan": [
                "Continue the current doses; consider tapering if pain stays low after chemotherapy"
              ]
            },
            {
              "display": "Goals of care",
              "assessment": "Goals-of-care conversation with Mrs. Lovelace, with the palliative care physician present. She understands that the cancer is responding but cannot be cured. Her hopes are to keep working on her mathematics and to stay at home; her fears are pain and losing her clarity of mind. She wants to continue treatment while it allows that, and she chose not to have resuscitation attempted if her heart stops, while keeping all other treatment. A portable medical order was completed",
              "plan": [
                "Share the order with the oncology and palliative care teams",
                "Revisit at each restaging"
              ]
            }
          ],
          "monitoring": [
            {
              "domain": "laboratory",
              "measure": "Blood count (hemoglobin, white cells, neutrophils, platelets)",
              "cadence": "Before each chemotherapy cycle and at each visit",
              "status": "completed_today",
              "detail": "Hemoglobin 10.6 g/dL, white cells 3.8, neutrophils 1.9, platelets 172",
              "observation_ids": [
                "OBS-HGB-V4",
                "OBS-WBC-V4",
                "OBS-ANC-V4",
                "OBS-PLT-V4"
              ],
              "guideline_ids": [
                "GL-NCCN-CERV-2026",
                "GL-KN826-2021",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Creatinine, eGFR and ALT",
              "cadence": "Before each cycle",
              "status": "completed_today",
              "detail": "Creatinine 0.72 mg/dL, eGFR 112, ALT 26 U/L",
              "observation_ids": [
                "OBS-CREAT-V4",
                "OBS-EGFR-V4",
                "OBS-ALT-V4"
              ],
              "guideline_ids": [
                "GL-NCCN-CERV-2026",
                "GL-KN826-2021"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "TSH and free T4 on pembrolizumab",
              "cadence": "Baseline, then every 6 weeks",
              "status": "completed_today",
              "detail": "TSH 3.4 mIU/L. Protocol deviation: the TSH and free T4 due six weeks after baseline were not drawn, because they were left to be added to the cycle 3 blood tests and were not ordered; drawn today, twelve weeks after baseline. No harm resulted: TSH is normal and she has no thyroid symptoms. Corrective action: a standing order for TSH and free T4 every six weeks while she takes pembrolizumab",
              "observation_ids": [
                "OBS-TSH-V4"
              ],
              "guideline_ids": [
                "GL-ASCO-IRAE-2021"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Ferritin after intravenous iron",
              "cadence": "6 to 8 weeks after the infusions",
              "status": "completed_today",
              "detail": "Ferritin 210 ng/mL. Protocol deviation: the ferritin due 6 to 8 weeks after the second infusion was not drawn at the preventive visit, which fell in that window; drawn today, twelve weeks after. No harm resulted: stores are replete and hemoglobin is rising. Corrective action: list post-infusion tests on the problem list with their due dates",
              "observation_ids": [
                "OBS-FERR-V4"
              ],
              "guideline_ids": [
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "examination",
              "measure": "Vaginal bleeding and transfusion need",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "No bleeding",
              "guideline_ids": [
                "GL-NCCN-CERV-2026"
              ]
            },
            {
              "domain": "examination",
              "measure": "Immune-related adverse effects: rash, diarrhea, cough, fatigue",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "None",
              "guideline_ids": [
                "GL-ASCO-IRAE-2021"
              ]
            },
            {
              "domain": "examination",
              "measure": "Peripheral neuropathy on paclitaxel",
              "cadence": "Before each paclitaxel cycle",
              "status": "completed_today",
              "detail": "Grade 1 sensory neuropathy of the toes",
              "guideline_ids": [
                "GL-NCCN-CERV-2026"
              ]
            },
            {
              "domain": "imaging",
              "measure": "Restaging CT of chest, abdomen and pelvis",
              "cadence": "Every 2 to 3 cycles during first-line therapy, then every 3 months",
              "status": "completed_today",
              "detail": "CT a week ago: partial response",
              "guideline_ids": [
                "GL-NCCN-CERV-2026"
              ]
            },
            {
              "domain": "survey",
              "measure": "Pain intensity (0 to 10) and function",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "Average 3 of 10",
              "observation_ids": [
                "OBS-PAIN-V4"
              ],
              "guideline_ids": [
                "GL-ASCO-OPIOID-2023"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Opioid adverse effects: sedation, confusion, nausea",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "No sedation",
              "guideline_ids": [
                "GL-ASCO-OPIOID-2023"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Bowel regimen and constipation",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "Regular",
              "guideline_ids": [
                "GL-ASCO-OPIOID-2023"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Naloxone, locked storage, one prescriber, prescription monitoring check",
              "cadence": "At each opioid change, and every 3 months",
              "status": "completed_today",
              "detail": "Naloxone in date; locked storage; monitoring check clear",
              "guideline_ids": [
                "GL-ASCO-OPIOID-2023",
                "GL-CDC-OPIOID-2022"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Signs of opioid use disorder",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "None",
              "guideline_ids": [
                "GL-ASCO-OPIOID-2023"
              ]
            },
            {
              "domain": "survey",
              "measure": "Depression screen (PHQ-9) and distress",
              "cadence": "Periodically",
              "status": "completed_today",
              "detail": "PHQ-9 7",
              "observation_ids": [
                "OBS-PHQ9-V4"
              ],
              "guideline_ids": [
                "GL-ASCO-PALL-2024",
                "GL-USPSTF-DEP-2023"
              ]
            },
            {
              "domain": "referral",
              "measure": "Specialist palliative care",
              "cadence": "Ongoing alongside cancer treatment",
              "status": "completed_today",
              "detail": "Palliative care physician joined today's conversation",
              "guideline_ids": [
                "GL-ASCO-PALL-2024"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Goals-of-care conversation",
              "cadence": "At diagnosis, at each restaging, and with any change",
              "status": "completed_today",
              "detail": "Recorded; resuscitation not to be attempted; all other treatment continues",
              "guideline_ids": [
                "GL-ASCO-PALL-2024",
                "GL-ASCO-COMM-2026"
              ]
            }
          ],
          "follow_up": "Cycles 5 and 6 every three weeks. Review a week after the last cycle",
          "guideline_ids": [
            "GL-NCCN-CERV-2026",
            "GL-KN826-2021",
            "GL-ASCO-IRAE-2021",
            "GL-ASCO-OPIOID-2023",
            "GL-ASCO-PALL-2024",
            "GL-ASCO-COMM-2026",
            "GL-CMID-2026"
          ]
        }
      },
      {
        "id": "ENC-005",
        "display": "Twenty-week review after the last chemotherapy cycle: blood counts, thyroid on pembrolizumab, tapering morphine, mood and her work",
        "status": "finished",
        "date": "2026-10-20",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        },
        "visit_type": "chronic_care",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "390906007",
          "display": "Follow-up encounter",
          "validation_status": "validated",
          "validated_on": "2026-11-06"
        },
        "documentation": {
          "chief_complaint": "Twenty-week review a week after the sixth and last chemotherapy cycle: blood counts, thyroid on pembrolizumab, tapering morphine, mood and her work",
          "hpi": {
            "narrative": "Mrs. Lovelace returns a week after her sixth and last cycle of carboplatin and paclitaxel; pembrolizumab continues every three weeks. She has had no bleeding. Her average pain is 2 of 10, and she has used a breakthrough dose only twice in the past month. She would like to take less morphine. The tingling in her toes is unchanged. She feels a little more tired than usual but has no cold intolerance, constipation beyond her usual, weight gain, or palpitations. Her mood is better and she is working on new mathematical notes most mornings.",
            "elements": [
              {
                "label": "Treatment",
                "value": "Six cycles completed; pembrolizumab continues"
              },
              {
                "label": "Pain",
                "value": "Average 2 of 10; two breakthrough doses in a month"
              },
              {
                "label": "Neuropathy",
                "value": "Mild, unchanged"
              },
              {
                "label": "Thyroid symptoms",
                "value": "Slightly more tired; no cold intolerance or weight gain"
              },
              {
                "label": "Work",
                "value": "New mathematical notes most mornings"
              }
            ]
          },
          "ros": [
            {
              "system": "Constitutional",
              "status": "positive",
              "finding": "A little more tired; weight steady"
            },
            {
              "system": "Endocrine",
              "status": "negative",
              "finding": "No cold intolerance, hair or skin change beyond chemotherapy, or palpitations"
            },
            {
              "system": "Neurological",
              "status": "positive",
              "finding": "Mild toe tingling, unchanged"
            },
            {
              "system": "Psychiatric",
              "status": "negative",
              "finding": "Mood better; PHQ-9 5"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Well, alert; blood pressure 114/72, pulse 78, weight 54.4 kg"
            },
            {
              "system": "Neck",
              "finding": "No thyroid enlargement or tenderness"
            },
            {
              "system": "Neurological",
              "finding": "Reflexes normal; grade 1 sensory neuropathy at the toes"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-003",
              "display": "Metastatic cervical adenocarcinoma, after six cycles; on pembrolizumab",
              "assessment": "Counts recovering: hemoglobin 10.9 g/dL, white cells 4.2, neutrophils 2.4, platelets 188; creatinine 0.71 mg/dL, ALT 24 U/L. TSH 7.8 mIU/L with a normal free T4 of 1.0 ng/dL: subclinical hypothyroidism, most likely immune-related thyroiditis from pembrolizumab, grade 1; under the ASCO guideline pembrolizumab continues and levothyroxine is not needed unless TSH rises above 10 or symptoms develop",
              "plan": [
                "Continue pembrolizumab every 3 weeks",
                "TSH and free T4 in six weeks under the standing order",
                "Restaging CT in about six weeks",
                "Influenza, COVID-19, second zoster and second hepatitis B vaccines today, between cycles"
              ]
            },
            {
              "problem_id": "PRB-004",
              "display": "Cancer-related pelvic pain, well controlled",
              "assessment": "Average 2 of 10 with almost no breakthrough doses after radiation and the tumor's response; she wants less morphine, and a slow reduction is appropriate",
              "plan": [
                "Long-acting morphine 15 mg at night only for two weeks, then stop",
                "Keep oral morphine 5 mg as needed and acetaminophen",
                "Telephone check in one week for any return of pain or withdrawal symptoms"
              ]
            },
            {
              "problem_id": "PRB-005",
              "display": "Long-term opioid therapy, tapering",
              "assessment": "Safe use throughout; no signs of use disorder",
              "plan": [
                "Keep naloxone at home; return unused morphine to a pharmacy take-back"
              ]
            },
            {
              "problem_id": "PRB-002",
              "display": "Anemia",
              "assessment": "Hemoglobin 10.9 g/dL after chemotherapy; no bleeding",
              "plan": [
                "Blood count with pembrolizumab cycles"
              ]
            }
          ],
          "monitoring": [
            {
              "domain": "laboratory",
              "measure": "Blood count (hemoglobin, white cells, neutrophils, platelets)",
              "cadence": "Before each chemotherapy cycle and at each visit",
              "status": "completed_today",
              "detail": "Hemoglobin 10.9 g/dL, white cells 4.2, neutrophils 2.4, platelets 188",
              "observation_ids": [
                "OBS-HGB-V5",
                "OBS-WBC-V5",
                "OBS-ANC-V5",
                "OBS-PLT-V5"
              ],
              "guideline_ids": [
                "GL-NCCN-CERV-2026",
                "GL-KN826-2021",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Creatinine, eGFR and ALT",
              "cadence": "Before each cycle",
              "status": "completed_today",
              "detail": "Creatinine 0.71 mg/dL, eGFR 114, ALT 24 U/L",
              "observation_ids": [
                "OBS-CREAT-V5",
                "OBS-EGFR-V5",
                "OBS-ALT-V5"
              ],
              "guideline_ids": [
                "GL-NCCN-CERV-2026",
                "GL-KN826-2021"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "TSH and free T4 on pembrolizumab",
              "cadence": "Baseline, then every 6 weeks",
              "status": "completed_today",
              "detail": "TSH 7.8 mIU/L, free T4 1.0 ng/dL, six weeks after the last check; subclinical; repeat in six weeks",
              "observation_ids": [
                "OBS-TSH-V5",
                "OBS-FT4-V5"
              ],
              "guideline_ids": [
                "GL-ASCO-IRAE-2021"
              ]
            },
            {
              "domain": "examination",
              "measure": "Vaginal bleeding and transfusion need",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "No bleeding",
              "guideline_ids": [
                "GL-NCCN-CERV-2026"
              ]
            },
            {
              "domain": "examination",
              "measure": "Immune-related adverse effects: rash, diarrhea, cough, fatigue",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "Mild tiredness only",
              "guideline_ids": [
                "GL-ASCO-IRAE-2021"
              ]
            },
            {
              "domain": "examination",
              "measure": "Peripheral neuropathy on paclitaxel",
              "cadence": "With taxane treatment and after",
              "status": "completed_today",
              "detail": "Grade 1, unchanged",
              "guideline_ids": [
                "GL-NCCN-CERV-2026"
              ]
            },
            {
              "domain": "imaging",
              "measure": "Restaging CT of chest, abdomen and pelvis",
              "cadence": "Every 2 to 3 cycles during first-line therapy, then every 3 months",
              "status": "due",
              "detail": "About three months after the last CT, in six weeks",
              "guideline_ids": [
                "GL-NCCN-CERV-2026"
              ]
            },
            {
              "domain": "survey",
              "measure": "Pain intensity (0 to 10) and function",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "Average 2 of 10",
              "observation_ids": [
                "OBS-PAIN-V5"
              ],
              "guideline_ids": [
                "GL-ASCO-OPIOID-2023"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Opioid taper when pain improves",
              "cadence": "When pain is controlled after treatment",
              "status": "completed_today",
              "detail": "Long-acting morphine reduced to nightly for two weeks, then stopped",
              "guideline_ids": [
                "GL-ASCO-OPIOID-2023",
                "GL-CDC-OPIOID-2022"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Opioid adverse effects: sedation, confusion, nausea",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "No sedation",
              "guideline_ids": [
                "GL-ASCO-OPIOID-2023"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Bowel regimen and constipation",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "Regular",
              "guideline_ids": [
                "GL-ASCO-OPIOID-2023"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Naloxone, locked storage, one prescriber, prescription monitoring check",
              "cadence": "At each opioid change",
              "status": "completed_today",
              "detail": "Naloxone in date; take-back advised",
              "guideline_ids": [
                "GL-ASCO-OPIOID-2023",
                "GL-CDC-OPIOID-2022"
              ]
            },
            {
              "domain": "survey",
              "measure": "Depression screen (PHQ-9) and distress",
              "cadence": "Periodically",
              "status": "completed_today",
              "detail": "PHQ-9 5",
              "observation_ids": [
                "OBS-PHQ9-V5"
              ],
              "guideline_ids": [
                "GL-ASCO-PALL-2024",
                "GL-USPSTF-DEP-2023"
              ]
            },
            {
              "domain": "referral",
              "measure": "Specialist palliative care",
              "cadence": "Ongoing alongside cancer treatment",
              "status": "up_to_date",
              "detail": "Monthly palliative care visits",
              "guideline_ids": [
                "GL-ASCO-PALL-2024"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Goals-of-care conversation",
              "cadence": "At each restaging",
              "status": "up_to_date",
              "detail": "Recorded six weeks ago; to revisit after the next CT",
              "guideline_ids": [
                "GL-ASCO-PALL-2024",
                "GL-ASCO-COMM-2026"
              ]
            }
          ],
          "follow_up": "Telephone check in one week. Review after the restaging CT in about six weeks",
          "guideline_ids": [
            "GL-NCCN-CERV-2026",
            "GL-KN826-2021",
            "GL-ASCO-IRAE-2021",
            "GL-ASCO-OPIOID-2023",
            "GL-CDC-OPIOID-2022",
            "GL-ASCO-PALL-2024",
            "GL-CDC-IMZ-MED-2026"
          ]
        }
      },
      {
        "id": "ENC-006",
        "display": "Periodic adult preventive visit",
        "status": "finished",
        "date": "2026-08-18",
        "visit_type": "preventive_adult",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "86013001",
          "display": "Periodic reevaluation and management of healthy individual",
          "validation_status": "validated",
          "validated_on": "2026-11-06"
        },
        "documentation": {
          "chief_complaint": "Periodic adult preventive visit",
          "billing_note": "CPT 99395 (periodic preventive medicine, established patient, age 18 to 39) with CPT 99497 (advance care planning), both on the same day",
          "health_risk_assessment_method": "Completed by the patient on paper in the waiting room and reviewed with her face to face by Dr. Whitley-Adeyemi",
          "hpi": {
            "narrative": "Mrs. Lovelace is a 35-year-old mathematician with stage IVB adenocarcinoma of the cervix, on carboplatin, paclitaxel and pembrolizumab, who comes for a preventive visit. She had her third cycle a week ago. There has been no bleeding since the pelvic radiation. Her average pelvic pain is about 3 of 10 on long-acting morphine 15 mg twice a day, with one or two breakthrough doses on some days, and she is not drowsy in the mornings. Her bowels open every day or two since the laxatives were increased. She has mild tingling in her toes. She is working on her mathematics most mornings. She would like her vaccinations brought up to date while she is on treatment, and to set down her wishes.",
            "elements": [
              {
                "label": "Visit",
                "value": "Periodic adult preventive visit, age 35"
              },
              {
                "label": "Treatment",
                "value": "Three cycles of carboplatin, paclitaxel and pembrolizumab"
              },
              {
                "label": "Pain",
                "value": "About 3 of 10 on long-acting morphine; no morning drowsiness"
              },
              {
                "label": "Bowels",
                "value": "Opening every day or two"
              },
              {
                "label": "Mood",
                "value": "PHQ-2 2"
              }
            ]
          },
          "health_risk_assessment": [
            {
              "domain": "Self-rated health",
              "finding": "Fair; better than in the spring"
            },
            {
              "domain": "Psychosocial",
              "finding": "Worried about her debts and about her family; supported at home"
            },
            {
              "domain": "Tobacco",
              "finding": "Never"
            },
            {
              "domain": "Alcohol",
              "finding": "None since diagnosis; AUDIT-C 0"
            },
            {
              "domain": "Gambling",
              "finding": "Has stopped betting since her diagnosis; would like help with the debts"
            },
            {
              "domain": "Physical activity",
              "finding": "Short walks most days"
            },
            {
              "domain": "Nutrition",
              "finding": "Appetite fair; weight steady"
            },
            {
              "domain": "Sleep",
              "finding": "Seven hours, broken on the nights after chemotherapy"
            },
            {
              "domain": "Safety",
              "finding": "Feels safe at home; morphine kept in a locked box; naloxone at home"
            },
            {
              "domain": "Sexual health",
              "finding": "Not sexually active since the bleeding began"
            },
            {
              "domain": "Activities of daily living",
              "finding": "Independent"
            },
            {
              "domain": "Hearing and vision",
              "finding": "No concerns"
            }
          ],
          "ros": [
            {
              "system": "Constitutional",
              "status": "positive",
              "finding": "Tiredness for a few days after each cycle; no fever or night sweats"
            },
            {
              "system": "Eyes",
              "status": "negative",
              "finding": "No change in vision"
            },
            {
              "system": "Ears, nose, mouth, and throat",
              "status": "negative",
              "finding": "No mouth ulcers"
            },
            {
              "system": "Cardiovascular",
              "status": "negative",
              "finding": "No chest pain or leg swelling"
            },
            {
              "system": "Respiratory",
              "status": "negative",
              "finding": "No cough or breathlessness"
            },
            {
              "system": "Gastrointestinal",
              "status": "negative",
              "finding": "Bowels regular on laxatives; mild nausea for two days after each cycle"
            },
            {
              "system": "Genitourinary",
              "status": "negative",
              "finding": "No vaginal bleeding since radiation; light discharge; no urinary symptoms"
            },
            {
              "system": "Musculoskeletal",
              "status": "negative",
              "finding": "No joint pain"
            },
            {
              "system": "Integumentary",
              "status": "positive",
              "finding": "Hair thinning on chemotherapy; no rash"
            },
            {
              "system": "Neurological",
              "status": "positive",
              "finding": "Mild tingling in the toes, not affecting walking"
            },
            {
              "system": "Endocrine",
              "status": "negative",
              "finding": "No heat or cold intolerance"
            },
            {
              "system": "Psychiatric",
              "status": "negative",
              "finding": "Mood fair; PHQ-2 score 2"
            }
          ],
          "exam": [
            {
              "system": "Constitutional",
              "finding": "Slender, alert; weight 53.6 kg, BMI 19.7; blood pressure 110/70, pulse 80"
            },
            {
              "system": "Mouth",
              "finding": "No mucositis or thrush"
            },
            {
              "system": "Neck",
              "finding": "No thyroid enlargement; no lymph node enlargement"
            },
            {
              "system": "Cardiovascular",
              "finding": "Regular rhythm; no murmur"
            },
            {
              "system": "Respiratory",
              "finding": "Clear to auscultation bilaterally"
            },
            {
              "system": "Abdomen",
              "finding": "Soft; mild suprapubic tenderness; no masses"
            },
            {
              "system": "Skin",
              "finding": "Diffuse hair thinning; no rash"
            },
            {
              "system": "Neurological",
              "finding": "Light touch slightly reduced at the toes; vibration normal; gait normal"
            },
            {
              "system": "Psychiatric",
              "finding": "Engaged and humorous; not sedated"
            }
          ],
          "assessment_plan": [
            {
              "display": "Periodic adult preventive visit completed",
              "assessment": "Health risk assessment reviewed and the prevention plan made for an adult on chemotherapy and immunotherapy. Inactivated vaccines are given between cycles: PCV20, the first recombinant zoster dose, Tdap, and the first hepatitis B dose. Live vaccines are not given. Cervical screening does not apply; breast cancer screening is not yet due",
              "plan": [
                "Second zoster dose in one to two months and second hepatitis B dose in one to two months, at the twenty-week visit",
                "Influenza and COVID-19 vaccines when the autumn vaccines are available",
                "Annual preventive visit in one year"
              ]
            },
            {
              "problem_id": "PRB-004",
              "display": "Cancer-related pelvic pain",
              "assessment": "Controlled at about 3 of 10 on long-acting morphine without sedation",
              "plan": [
                "Continue the current doses; review at the fourteen-week visit"
              ]
            },
            {
              "problem_id": "PRB-005",
              "display": "Long-term opioid therapy",
              "assessment": "Taking morphine as prescribed from one prescriber; locked storage; naloxone at home",
              "plan": [
                "Continue the safety plan"
              ]
            },
            {
              "display": "Gambling debts",
              "assessment": "She has stopped betting and feels ashamed of the debts; the stress of them affects her sleep",
              "plan": [
                "A social worker for debt advice; problem gambling support offered and accepted"
              ]
            }
          ],
          "prevention_plan": [
            {
              "service": "Blood pressure",
              "status": "completed_today",
              "detail": "110/70 mmHg",
              "guideline_ids": [
                "GL-USPSTF-AB"
              ]
            },
            {
              "service": "Depression screening",
              "status": "completed_today",
              "detail": "PHQ-2 score 2; PHQ-9 9 five weeks ago",
              "guideline_ids": [
                "GL-USPSTF-DEP-2023"
              ]
            },
            {
              "service": "Tobacco use",
              "status": "completed_today",
              "detail": "Never used tobacco",
              "guideline_ids": [
                "GL-USPSTF-AB"
              ]
            },
            {
              "service": "Unhealthy alcohol use",
              "status": "completed_today",
              "detail": "AUDIT-C 0; no alcohol since diagnosis",
              "guideline_ids": [
                "GL-USPSTF-ALC-2018"
              ]
            },
            {
              "service": "Intimate partner violence screening",
              "status": "completed_today",
              "detail": "Screened in private; negative",
              "guideline_ids": [
                "GL-USPSTF-IPV-2018"
              ]
            },
            {
              "service": "HIV screening",
              "status": "up_to_date",
              "detail": "Nonreactive at diagnosis",
              "guideline_ids": [
                "GL-USPSTF-HIV-2019"
              ]
            },
            {
              "service": "Hepatitis C screening",
              "status": "up_to_date",
              "detail": "Antibody nonreactive at diagnosis",
              "guideline_ids": [
                "GL-USPSTF-HCV-2020"
              ]
            },
            {
              "service": "Hepatitis B screening and vaccination",
              "status": "completed_today",
              "detail": "Surface antigen, core antibody and surface antibody all negative before treatment; CpG-adjuvanted vaccine dose 1 of 2 today",
              "guideline_ids": [
                "GL-ASCO-HBV-2020",
                "GL-CDC-HBVAX-2022"
              ]
            },
            {
              "service": "Pneumococcal vaccine",
              "status": "completed_today",
              "detail": "PCV20 today for an immunocompromising condition",
              "guideline_ids": [
                "GL-CDC-IMZ-MED-2026"
              ]
            },
            {
              "service": "Zoster vaccine",
              "status": "completed_today",
              "detail": "Recombinant zoster vaccine dose 1 of 2 today, recommended from 19 for immunocompromised adults",
              "guideline_ids": [
                "GL-CDC-IMZ-MED-2026"
              ]
            },
            {
              "service": "Tetanus, diphtheria, and pertussis",
              "status": "completed_today",
              "detail": "Tdap today",
              "guideline_ids": [
                "GL-CDC-IMZ-MED-2026"
              ]
            },
            {
              "service": "Influenza vaccine",
              "status": "due",
              "detail": "Inactivated vaccine in the autumn, between cycles",
              "guideline_ids": [
                "GL-CDC-IMZ-MED-2026"
              ]
            },
            {
              "service": "COVID-19 vaccine",
              "status": "due",
              "detail": "Current vaccine in the autumn; recommended for immunocompromised adults",
              "guideline_ids": [
                "GL-CDC-IMZ-MED-2026"
              ]
            },
            {
              "service": "HPV vaccine",
              "status": "not_indicated",
              "detail": "Age 35 and already diagnosed with an HPV-related cancer",
              "guideline_ids": [
                "GL-CDC-IMZ-MED-2026"
              ]
            },
            {
              "service": "Live vaccines",
              "status": "not_indicated",
              "detail": "Contraindicated during chemotherapy and immunotherapy",
              "guideline_ids": [
                "GL-CDC-IMZ-MED-2026"
              ]
            },
            {
              "service": "Cervical cancer screening",
              "status": "not_indicated",
              "detail": "Under treatment for cervical cancer",
              "guideline_ids": [
                "GL-USPSTF-AB"
              ]
            },
            {
              "service": "Breast cancer screening",
              "status": "not_indicated",
              "detail": "Not due before 40 at average risk",
              "guideline_ids": [
                "GL-USPSTF-AB"
              ]
            },
            {
              "service": "Diabetes and lipid screening",
              "status": "not_indicated",
              "detail": "Not a priority during treatment; BMI 19.7",
              "guideline_ids": [
                "GL-USPSTF-AB"
              ]
            },
            {
              "service": "Contraception and pregnancy",
              "status": "completed_today",
              "detail": "Not sexually active; told that chemotherapy and pembrolizumab can harm a pregnancy and to use contraception if that changes",
              "guideline_ids": [
                "GL-NCCN-CERV-2026"
              ]
            }
          ],
          "advance_care_planning": "Voluntary advance care planning discussion of about 30 minutes, with her consent, in the context of metastatic cancer. She named a health care agent and an alternate, recorded in the chart and not named here, and completed a health care proxy form. She wants treatment aimed at living longer while it lets her think and work, wants to be told the truth about her illness directly, and does not want her life prolonged by machines if she could no longer think clearly. Her wishes on resuscitation will be revisited after the restaging scan. A copy was sent to her oncology and palliative care teams.",
          "follow_up": "Fourteen-week review in three weeks, after the restaging CT",
          "guideline_ids": [
            "GL-PREV-2026",
            "GL-USPSTF-AB",
            "GL-CDC-IMZ-MED-2026",
            "GL-ASCO-PALL-2024"
          ]
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic periodic preventive visit.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "ENC-007",
        "display": "Same-day sick visit for constipation",
        "status": "finished",
        "date": "2026-07-07",
        "visit_type": "sick",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "185345009",
          "display": "Encounter for symptom",
          "validation_status": "validated",
          "validated_on": "2026-11-06"
        },
        "documentation": {
          "chief_complaint": "No bowel movement for five days, with bloating and cramps",
          "billing_note": "Problem-oriented office visit, established patient",
          "hpi": {
            "narrative": "Mrs. Lovelace asked for a same-day visit. She had her first cycle of carboplatin, paclitaxel and pembrolizumab a week ago and took ondansetron twice a day for three days after it. She takes long-acting morphine 15 mg twice a day, with one or two 5 mg doses of the oral solution on some days, senna two tablets at night and polyethylene glycol once a day, though she missed some doses of the laxatives while she felt sick. She has not opened her bowels for five days. She feels bloated with cramping in the lower abdomen, but she is passing wind, has not vomited, and is eating a little. She has no fever. The vaginal bleeding has stopped since the radiation. Her pelvic pain is no worse.",
            "elements": [
              {
                "label": "Onset",
                "value": "No bowel movement since five days ago"
              },
              {
                "label": "Location",
                "value": "Lower abdomen"
              },
              {
                "label": "Duration",
                "value": "Five days"
              },
              {
                "label": "Character",
                "value": "Bloating and cramping"
              },
              {
                "label": "Severity",
                "value": "Cramps 4 of 10"
              },
              {
                "label": "Timing",
                "value": "Constant bloating; intermittent cramps"
              },
              {
                "label": "Context",
                "value": "First chemotherapy cycle a week ago; ondansetron for three days; long-acting morphine; missed laxative doses"
              },
              {
                "label": "Modifying factors",
                "value": "Passing wind eases the cramps"
              },
              {
                "label": "Associated signs and symptoms",
                "value": "Mild nausea; no vomiting, fever, or bleeding"
              }
            ]
          },
          "ros": [
            {
              "system": "Constitutional",
              "status": "negative",
              "finding": "No fever or chills"
            },
            {
              "system": "Gastrointestinal",
              "status": "positive",
              "finding": "No stool for five days, bloating, cramps, mild nausea; passing wind; no vomiting or blood"
            },
            {
              "system": "Genitourinary",
              "status": "negative",
              "finding": "No vaginal bleeding; passing urine normally"
            },
            {
              "system": "Neurological",
              "status": "negative",
              "finding": "No confusion or drowsiness"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Comfortable at rest; temperature 36.7 C, blood pressure 110/70, pulse 88"
            },
            {
              "system": "Abdomen",
              "finding": "Mildly distended and soft, with active bowel sounds; mild tenderness in the left lower quadrant over palpable stool; no guarding, rebound, or tympanic distension"
            },
            {
              "system": "Mental status",
              "finding": "Alert and clear; pupils normal size; not sedated"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-006",
              "display": "Drug-induced constipation",
              "assessment": "Constipation from long-acting morphine and ondansetron, made worse by missed laxatives, in the first week after chemotherapy. She is passing wind, not vomiting, and the abdomen is soft with active bowel sounds, so bowel obstruction is unlikely and imaging is not needed. Potassium 3.8 mmol/L and calcium 9.3 mg/dL are normal. Opioid-induced constipation does not improve with time, so the laxatives must be taken every day while she takes morphine",
              "plan": [
                "Polyethylene glycol 17 g twice a day and senna two tablets twice a day until the bowels open, then back to the usual doses every day",
                "If there is no bowel movement in 48 hours, call: a peripherally acting opioid antagonist will be considered",
                "Ondansetron only as needed after the first day of each future cycle",
                "Fluids and short walks",
                "Go to the emergency department for vomiting, severe pain, a swollen tight abdomen, or no wind"
              ]
            },
            {
              "problem_id": "PRB-004",
              "display": "Cancer-related pelvic pain",
              "assessment": "No worse; morphine unchanged",
              "plan": [
                "Continue long-acting morphine 15 mg twice a day"
              ]
            }
          ],
          "follow_up": "Telephone check in two days. Six-week review next week",
          "guideline_ids": [
            "GL-ASCO-OPIOID-2023"
          ]
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic unscheduled sick visit; the constipation is a synthetic adverse drug effect, not a historical claim.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      }
    ],
    "vital_sign_sets": [
      {
        "id": "VSET-001",
        "date": "2026-06-02",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 165,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 54.0,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 19.8,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 108,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 68,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 96,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 16,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.8,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 98,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seated vital signs; no measurement from her lifetime is used.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "VSET-002",
        "date": "2026-06-16",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 165,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 54.2,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 19.9,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 106,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 66,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 92,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 16,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.7,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 98,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seated vital signs; no measurement from her lifetime is used.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "VSET-003",
        "date": "2026-07-14",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 165,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 53.4,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 19.6,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 110,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 70,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 84,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 16,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.6,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 98,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seated vital signs; no measurement from her lifetime is used.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "VSET-004",
        "date": "2026-09-08",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 165,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 54.0,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 19.8,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 112,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 70,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 80,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 16,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.7,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 98,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seated vital signs; no measurement from her lifetime is used.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "VSET-005",
        "date": "2026-10-20",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 165,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 54.4,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 20.0,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 114,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 72,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 78,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 16,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.6,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 98,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seated vital signs; no measurement from her lifetime is used.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "VSET-006",
        "date": "2026-08-18",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 165,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 53.6,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 19.7,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 110,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 70,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 80,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 16,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.6,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 98,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seated vital signs at the preventive visit, one week after the third chemotherapy cycle.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "VSET-007",
        "date": "2026-07-07",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 165,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 53.8,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 19.8,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 110,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 70,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 88,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 16,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.7,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 98,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic vital signs at the sick visit.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      }
    ],
    "social_history": [
      {
        "id": "SOC-001",
        "display": "Mathematician; writes on calculating machines and is drafting new mathematical notes; works best in the mornings",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic modern work history anchored to her documented 1843 Notes.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "SOC-002",
        "display": "Married, a countess by marriage; lives in her family's London house; household help available",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0003"
          ],
          "synthetic_reason": "Synthetic household history anchored to her documented marriage and title; no health facts or decisions are recorded for any family member.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "SOC-003",
        "display": "Gambling: bets on horse races; has borrowed money and pawned jewelry to cover losses and feels ashamed of the debts; Brief Problem Gambling Screen positive",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008"
          ],
          "synthetic_reason": "Synthetic modern history anchored to her documented gambling and debts; no gambling disorder is diagnosed.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "SOC-004",
        "display": "Tobacco: never. Alcohol: a glass of wine some evenings, none since the bleeding began; no other drugs",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic history; not a claim about her real habits.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "SOC-005",
        "display": "Contraception: none needed by her account; serum hCG negative",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic history.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      }
    ],
    "functional_status": [
      {
        "id": "FUNC-001",
        "display": "Independent in self-care; tires on stairs; ECOG performance status 1",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic functional status.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      }
    ],
    "mental_status": [
      {
        "id": "MSE-001",
        "display": "Alert, quick and articulate; anxious about the bleeding; mild low mood; PHQ-9 score 8, no thoughts of death or self-harm; no opioid craving or use beyond what is prescribed",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005",
            "CLM-0007"
          ],
          "synthetic_reason": "Synthetic mental-status finding; not a claim about her real mood.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      }
    ],
    "consultation": {
      "referral": {
        "question": "Friable exophytic cervical mass with five months of abnormal bleeding and constant pelvic pain in a 35-year-old woman, biopsied today, with iron deficiency anemia. Please confirm the diagnosis, stage the disease, advise on treatment intent and options, and help with control of bleeding and pain",
        "urgency": "Within two weeks; pathology expected within a week",
        "pertinent_history": "Mathematician, 35, with five months of bleeding between periods and after intercourse, heavier periods, a watery blood-stained discharge, and a constant pelvic ache, average 7 of 10. She has taken prescribed opium tincture, 0.5 mL four to six times a day and measured at times with a household spoon, for about two years for recurrent pelvic and abdominal pain; today it was changed to measured oral morphine solution 5 mg every 4 hours as needed, with acetaminophen, laxatives and naloxone. No opioid use disorder on assessment. Earlier history of measles in childhood, cholera in her early twenties, and chronic ill health with asthma and digestive problems. Never smoked. On speculum examination a 5 cm friable exophytic mass replaces the cervix and bleeds on contact; on bimanual and rectovaginal examination the left parametrium feels thickened, not reaching the sidewall. Punch biopsy and HPV typing sent. Hemoglobin 8.4 g/dL, mean cell volume 74 fL, ferritin 5 ng/mL, platelets 412; creatinine 0.68 mg/dL; ALT 18 U/L; albumin 3.6 g/dL; serum hCG negative. First intravenous iron infusion given today. PHQ-9 8. She wants to be told everything directly and to make her own decisions, and she wants to keep her mind clear for her work",
        "questions": [
          "What is the diagnosis, and what further staging is needed?",
          "Is the intent of treatment curative or palliative, and what treatment do you recommend?",
          "How should the bleeding be controlled?",
          "Which tumor or genetic tests are needed?",
          "How should her pain and long-term opioid therapy be managed during treatment?",
          "When should palliative care be involved?"
        ]
      },
      "consultant_note": {
        "history": "Mrs. Lovelace, a 35-year-old mathematician, is seen at the request of Dr. Whitley-Adeyemi for a cervical mass found two weeks ago after five months of abnormal bleeding and pelvic pain. The bleeding is lighter since the first iron infusion but continues. Her pain averages 6 of 10 on oral morphine solution 5 mg about six times a day, without drowsiness; she stopped the opium tincture she had taken for two years. She has no cough, hemoptysis, bone pain, leg swelling, or urinary or bowel symptoms beyond opioid-related constipation. She has never had cervical screening. She does not wish to preserve fertility. She asked to be told the findings directly",
        "data_reviewed": "Cervical biopsy: invasive adenocarcinoma, usual (HPV-associated) type, p16 diffusely positive, HPV 18 detected; PD-L1 combined positive score 5; mismatch repair proteins retained; HER2 immunohistochemistry 1+. Pelvic MRI a week ago: 5.2 cm endocervical tumor with left parametrial invasion, not reaching the sidewall, no hydronephrosis, an enlarged left external iliac node. FDG PET-CT five days ago: avid tumor, avid left pelvic and para-aortic nodes, six avid nodules in both lungs up to 1.4 cm, no bone or liver lesions. Hemoglobin 9.0 g/dL today, from 8.4; creatinine 0.66 mg/dL; ALT 17 U/L; TSH 1.9 mIU/L; HIV, hepatitis B and hepatitis C tests negative",
        "exam": [
          {
            "system": "General",
            "finding": "Pale, alert, not sedated; blood pressure 106/66, pulse 92; ECOG performance status 1"
          },
          {
            "system": "Lymph nodes",
            "finding": "No supraclavicular or inguinal lymph node enlargement"
          },
          {
            "system": "Abdomen",
            "finding": "Soft; mild suprapubic tenderness; no masses"
          },
          {
            "system": "Pelvis",
            "finding": "Exophytic friable cervical tumor about 5 cm with light bleeding; left parametrial thickening not reaching the sidewall; vagina free; rectovaginal septum free"
          }
        ],
        "assessment": [
          {
            "problem_id": "PRB-003",
            "display": "Adenocarcinoma of the cervix, HPV 18 positive, FIGO 2018 stage IVB by imaging",
            "assessment": "The lung nodules and para-aortic nodes on PET-CT mean distant spread, stage IVB by imaging; because this decides that treatment is palliative rather than curative, a lung nodule should be biopsied to confirm it before systemic therapy. With PD-L1 combined positive score 5, the NCCN preferred first-line treatment is carboplatin or cisplatin with paclitaxel and pembrolizumab, with or without bevacizumab, based on KEYNOTE-826. I recommend carboplatin, for ease and less toxicity, and leaving out bevacizumab for now, because she is bleeding from the tumor and will have pelvic radiation, which raise the risks of hemorrhage and fistula. Cervical cancer is not part of a hereditary cancer syndrome, so germline testing is not indicated; the tumor biomarkers are complete for first-line and later choices"
          },
          {
            "problem_id": "PRB-002",
            "display": "Iron deficiency anemia from tumor bleeding",
            "assessment": "Bleeding will not stop without treating the tumor. A short course of palliative pelvic radiation controls bleeding in most patients within one to two weeks. Transfusion if hemoglobin falls below 7 to 8 g/dL or she has symptoms"
          },
          {
            "problem_id": "PRB-004",
            "display": "Cancer-related pelvic pain",
            "assessment": "Constant visceral and nociceptive pain from the tumor and parametrial spread, needing scheduled opioid therapy, which radiation and systemic treatment should also reduce. Her long prior use of opium tincture does not argue against opioids for cancer pain, but calls for clear, measured dosing, one prescriber, and attention to sedation, given her wish for a clear mind"
          }
        ],
        "recommendations": [
          "CT-guided biopsy of a lung nodule to confirm metastatic disease",
          "Palliative pelvic radiation, 20 Gy in 5 fractions, starting next week, for bleeding and pain",
          "Then carboplatin (AUC 5), paclitaxel 175 mg/m2 and pembrolizumab 200 mg every 3 weeks for six cycles, with pembrolizumab continuing as maintenance; no bevacizumab for now",
          "Blood counts, creatinine and ALT before each cycle; TSH and free T4 at baseline and every six weeks on pembrolizumab; restaging CT after four cycles",
          "No germline genetic testing",
          "Long-acting morphine 15 mg every 12 hours with morphine solution 5 mg as needed for breakthrough pain, a daily bowel regimen, naloxone, and one prescriber, under Dr. Whitley-Adeyemi with the palliative care team",
          "Specialist palliative care alongside treatment from today",
          "Complete intravenous iron; transfuse only below 7 to 8 g/dL or for symptoms"
        ],
        "communication": "Dr. Whitley-Adeyemi and I gave Mrs. Lovelace the diagnosis together, at her request, in plain words: the cancer has spread and cannot be cured, and treatment aims to stop the bleeding, ease the pain, control the cancer and help her live longer and well. She asked about treatment and its effects on her thinking, and chose radiation and chemotherapy with pembrolizumab. The palliative care team saw her the same afternoon",
        "follow_up": "Gynecologic oncology after the lung biopsy and before the first cycle, then before each cycle, with restaging after four cycles"
      },
      "guideline_ids": [
        "GL-NCCN-CERV-2026",
        "GL-FIGO-2018",
        "GL-KN826-2021",
        "GL-ASCO-PALL-2024",
        "GL-ASCO-OPIOID-2023",
        "GL-ASCO-COMM-2026"
      ]
    }
  },
  "care_plan": {
    "health_concerns": [
      {
        "id": "HC-001",
        "display": "She wants to know plainly what the bleeding means and to make her own decisions",
        "status": "active",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic patient-centered concern.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "HC-002",
        "display": "She wants her mornings clear-headed for her mathematical work and fears that stronger pain medicine will cloud her mind",
        "status": "active",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006",
            "CLM-0005",
            "CLM-0007"
          ],
          "synthetic_reason": "Synthetic patient-centered concern anchored to her documented mathematical work and opium use.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      }
    ],
    "goals": [
      {
        "id": "GOAL-001",
        "display": "Average pelvic pain at or below 3 of 10 without daytime sedation",
        "status": "completed",
        "target_date": "2026-07-14",
        "outcome": "Average pain 3 of 10 after radiation, on long-acting morphine, without daytime sleepiness",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic pain goal set with her.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "GOAL-002",
        "display": "Bleeding controlled and hemoglobin above 10 g/dL without transfusion",
        "status": "completed",
        "target_date": "2026-09-08",
        "outcome": "No bleeding since radiation; hemoglobin 10.6 g/dL",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic anemia goal.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "GOAL-003",
        "display": "A documented goals-of-care conversation and a named health care agent",
        "status": "completed",
        "target_date": "2026-09-08",
        "outcome": "Advance care plan and goals-of-care conversation recorded",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic goal.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "GOAL-004",
        "display": "Able to work on her mathematics for at least two hours most mornings",
        "status": "completed",
        "target_date": "2026-10-20",
        "outcome": "Working most mornings",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic functional goal set with her.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      }
    ],
    "interventions": [
      {
        "id": "INT-001",
        "display": "Gynecologic oncology consultation in two weeks for a friable cervical mass with bleeding and pain, biopsied today: diagnosis, staging, treatment intent, bleeding control, and pain",
        "status": "completed",
        "guideline_ids": [
          "GL-NCCN-CERV-2026",
          "GL-FIGO-2018"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic specialist referral.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "INT-002",
        "display": "Stop opium tincture and change to measured oral morphine solution 5 mg every 4 hours as needed with an oral syringe, with acetaminophen, senna and polyethylene glycol, a naloxone nasal spray, a prescription monitoring check, locked storage, one prescriber, and review in two weeks",
        "status": "completed",
        "guideline_ids": [
          "GL-ASCO-OPIOID-2023",
          "GL-CDC-OPIOID-2022"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005",
            "CLM-0007"
          ],
          "synthetic_reason": "Synthetic opioid conversion and safety plan.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "INT-003",
        "display": "Iron deficiency anemia: ferric carboxymaltose 750 mg intravenously today and in two weeks, with a blood count at each visit and ferritin 6 to 8 weeks after the infusions",
        "status": "completed",
        "guideline_ids": [
          "GL-CMID-2026"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic anemia plan.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "INT-004",
        "display": "Blood tests: blood count, ferritin, creatinine, ALT, albumin and a pregnancy test; HIV, hepatitis B and hepatitis C tests before any cancer treatment; PHQ-9",
        "status": "completed",
        "guideline_ids": [
          "GL-ASCO-HBV-2020",
          "GL-USPSTF-DEP-2023"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic baseline evaluation.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "INT-005",
        "display": "Staging by FIGO 2018 with pelvic MRI and PET-CT, and a CT-guided biopsy of a lung nodule; tumor PD-L1, mismatch repair and HER2 testing; no germline testing, because cervical cancer is not a hereditary cancer syndrome",
        "status": "completed",
        "guideline_ids": [
          "GL-NCCN-CERV-2026",
          "GL-FIGO-2018"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic staging and biomarker plan decided at the consultation.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        },
        "recorded_date": "2026-06-16"
      },
      {
        "id": "INT-006",
        "display": "Palliative pelvic radiation, 20 Gy in 5 fractions, for bleeding and pain, then carboplatin, paclitaxel and pembrolizumab every 3 weeks for six cycles with pembrolizumab continuing, without bevacizumab while bleeding and after pelvic radiation; blood counts before each cycle and thyroid tests every six weeks",
        "status": "completed",
        "guideline_ids": [
          "GL-NCCN-CERV-2026",
          "GL-KN826-2021"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic treatment decided at the consultation.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        },
        "recorded_date": "2026-06-16"
      },
      {
        "id": "INT-007",
        "display": "Specialist palliative care alongside cancer treatment from diagnosis, for pain, symptoms, mood, and goals-of-care conversations, with long-acting morphine 15 mg every 12 hours and oral morphine 5 mg as needed for breakthrough pain",
        "status": "completed",
        "guideline_ids": [
          "GL-ASCO-PALL-2024",
          "GL-ASCO-OPIOID-2023",
          "GL-ASCO-COMM-2026"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic palliative care plan decided at the consultation.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        },
        "recorded_date": "2026-06-16"
      }
    ],
    "guidelines": [
      {
        "guideline_id": "GL-NCCN-CERV-2026",
        "title": "NCCN Clinical Practice Guidelines in Oncology: Cervical Cancer",
        "publisher": "National Comprehensive Cancer Network",
        "url": "https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1426",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-FIGO-2018",
        "title": "Revised FIGO staging for carcinoma of the cervix uteri (Bhatla N, et al. Int J Gynaecol Obstet 2019;145:129-135)",
        "publisher": "International Federation of Gynecology and Obstetrics",
        "url": "https://pubmed.ncbi.nlm.nih.gov/30656645/",
        "version_or_year": "2018"
      },
      {
        "guideline_id": "GL-KN826-2021",
        "title": "Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer (KEYNOTE-826; Colombo N, et al. N Engl J Med 2021;385:1856-1867)",
        "publisher": "New England Journal of Medicine",
        "url": "https://pubmed.ncbi.nlm.nih.gov/34534429/",
        "version_or_year": "2021"
      },
      {
        "guideline_id": "GL-ASCO-PALL-2024",
        "title": "Palliative Care for Patients With Cancer: ASCO Guideline Update (Sanders JJ, et al. J Clin Oncol 2024;42:2336-2357)",
        "publisher": "American Society of Clinical Oncology",
        "url": "https://pubmed.ncbi.nlm.nih.gov/38748941/",
        "version_or_year": "2024"
      },
      {
        "guideline_id": "GL-ASCO-OPIOID-2023",
        "title": "Use of Opioids for Adults With Pain From Cancer or Cancer Treatment: ASCO Guideline (Paice JA, et al. J Clin Oncol 2023;41:914-930)",
        "publisher": "American Society of Clinical Oncology",
        "url": "https://pubmed.ncbi.nlm.nih.gov/36469839/",
        "version_or_year": "2023"
      },
      {
        "guideline_id": "GL-CDC-OPIOID-2022",
        "title": "CDC Clinical Practice Guideline for Prescribing Opioids for Pain - United States, 2022 (Dowell D, et al. MMWR Recomm Rep 2022;71(RR-3):1-95)",
        "publisher": "Centers for Disease Control and Prevention",
        "url": "https://pubmed.ncbi.nlm.nih.gov/36327391/",
        "version_or_year": "2022"
      },
      {
        "guideline_id": "GL-ASCO-COMM-2026",
        "title": "Patient-Clinician Communication: ASCO Guideline Update (Gilligan T, et al. J Clin Oncol 2026;44:1040-1057)",
        "publisher": "American Society of Clinical Oncology",
        "url": "https://pubmed.ncbi.nlm.nih.gov/41805420/",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-ASCO-HBV-2020",
        "title": "Hepatitis B Virus Screening and Management for Patients With Cancer Prior to Therapy: ASCO Provisional Clinical Opinion Update (Hwang JP, et al. J Clin Oncol 2020;38:3698-3715)",
        "publisher": "American Society of Clinical Oncology",
        "url": "https://pubmed.ncbi.nlm.nih.gov/32716741/",
        "version_or_year": "2020"
      },
      {
        "guideline_id": "GL-CMID-2026",
        "title": "CMID: Clinical Monitoring Intelligence Database, anemia monograph",
        "publisher": "Aether Forge",
        "url": "https://patrickrutledge.github.io/topthirty/",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-USPSTF-DEP-2023",
        "title": "Depression and Suicide Risk in Adults: Screening",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/screening-depression-suicide-risk-adults",
        "version_or_year": "2023"
      },
      {
        "guideline_id": "GL-PREV-2026",
        "title": "Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements",
        "publisher": "Aether Forge",
        "url": "https://patrickrutledge.github.io/preventative_services/",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-USPSTF-AB",
        "title": "USPSTF A and B Recommendations",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation-topics/uspstf-a-and-b-recommendations",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-USPSTF-HIV-2019",
        "title": "Human Immunodeficiency Virus (HIV) Infection: Screening",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/human-immunodeficiency-virus-hiv-infection-screening",
        "version_or_year": "2019"
      },
      {
        "guideline_id": "GL-USPSTF-HCV-2020",
        "title": "Hepatitis C Virus Infection in Adolescents and Adults: Screening",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/hepatitis-c-screening",
        "version_or_year": "2020"
      },
      {
        "guideline_id": "GL-USPSTF-IPV-2018",
        "title": "Intimate Partner Violence, Elder Abuse, and Abuse of Vulnerable Adults: Screening",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/intimate-partner-violence-and-abuse-of-elderly-and-vulnerable-adults-screening",
        "version_or_year": "2018"
      },
      {
        "guideline_id": "GL-USPSTF-ALC-2018",
        "title": "Unhealthy Alcohol Use in Adolescents and Adults: Screening and Behavioral Counseling Interventions",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/unhealthy-alcohol-use-in-adolescents-and-adults-screening-and-behavioral-counseling-interventions",
        "version_or_year": "2018"
      },
      {
        "guideline_id": "GL-CDC-IMZ-MED-2026",
        "title": "Adult Immunization Schedule by Medical Condition and Other Indication",
        "publisher": "Centers for Disease Control and Prevention",
        "url": "https://www.cdc.gov/vaccines/hcp/imz-schedules/adult-medical-condition.html",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-CDC-HBVAX-2022",
        "title": "Universal Hepatitis B Vaccination in Adults Aged 19-59 Years: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2022 (Weng MK, et al. MMWR 2022;71(13):477-483)",
        "publisher": "Centers for Disease Control and Prevention",
        "url": "https://pubmed.ncbi.nlm.nih.gov/35358162/",
        "version_or_year": "2022"
      },
      {
        "guideline_id": "GL-ASCO-IRAE-2021",
        "title": "Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guideline Update (Schneider BJ, et al. J Clin Oncol 2021;39:4073-4126)",
        "publisher": "American Society of Clinical Oncology",
        "url": "https://pubmed.ncbi.nlm.nih.gov/34724392/",
        "version_or_year": "2021"
      }
    ]
  },
  "review": {
    "schema_validation": {
      "status": "not_started",
      "notes": "Run scripts/build.ps1 -Conformance."
    },
    "clinical_review": {
      "status": "not_started",
      "notes": "Awaiting clinician review; check the opium tincture to morphine conversion and titration, the stage IVB staging and lung biopsy, palliative radiation before systemic therapy, the omission of bevacizumab, the immune-related thyroid monitoring, the opioid taper, and the early palliative care."
    },
    "provenance_review": {
      "status": "not_started",
      "notes": "The Bodleian Libraries, the MacTutor archive (University of St Andrews), Smithsonian Magazine, Biography.com, a Historical Novels Review summary of Miranda Seymour's biography, the Computer History Museum and the Oxford Mathematical Institute logged. The laudanum and opium claim rests on a general biography and on her own words about opium and is graded probable. Bloodletting, cannabis and the details of the final illness were not verified and are left out."
    },
    "safe_messaging_review": {
      "status": "not_started",
      "notes": "Claims about opium, laudanum, gambling and debts are marked sensitive. The modern PHQ-9 scores (8, 9, 7, 5) are synthetic and below 10; no behavioral-health or substance use diagnosis is made, and no safety assessment is required. The modern episode makes no prediction about her death."
    }
  }
}
